{"gene":"NDRG1","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":1998,"finding":"Cap43 (NDRG1) mRNA is specifically induced by nickel compounds (Ni3S2 or NiCl2) via elevation of free intracellular Ca2+, as demonstrated by induction with calcium ionophores and attenuation by intracellular Ca2+ chelation; induction is not mimicked by oxidative stress or heat shock, and okadaic acid (a serine/threonine phosphatase inhibitor) induces Cap43 more strongly than nickel, implicating phosphatase-regulated signaling in its regulation.","method":"mRNA differential display, calcium ionophore treatment, intracellular Ca2+ chelation with BAPTA-AM, okadaic acid treatment, Northern blot in human and rodent cells","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal pharmacological manipulations in a single lab; specific induction mechanism via Ca2+ established","pmids":["9605764"],"is_preprint":false},{"year":1999,"finding":"Ndrg1 is transcriptionally repressed by N-myc: N-myc (and c-myc) together with Max down-regulate the Ndrg1 promoter through a region within 52 bp of the transcription start site, and this repression requires histone deacetylase activity (sensitive to Trichostatin A); direct binding of N-myc:Max to the promoter was not demonstrated, analogous to indirect repression mechanisms reported for c-myc targets.","method":"Promoter-reporter cotransfection assay, Trichostatin A treatment, whole-embryo cDNA subtraction in N-myc-deficient mice, in situ hybridization","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 2 — functional promoter deletion assays with pharmacological validation; single lab","pmids":["10381566"],"is_preprint":false},{"year":1996,"finding":"NDRG1 (originally named RTP) was first identified as a homocysteine-responsive gene product in vascular endothelial cells, also induced by 2-mercaptoethanol and tunicamycin (ER stress inducers), establishing it as a stress-responsive cytoplasmic protein.","method":"Differential display, Northern blot, full-length cDNA cloning from HUVEC library","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — original cloning with multiple stress inducers tested; single lab","pmids":["8939898"],"is_preprint":false},{"year":2000,"finding":"NDRG1 is phosphorylated by protein kinase A (PKA) at multiple sites (seven or more) in vitro and in cells; phosphorylation is reversible, enhanced by elevated intracellular cAMP, inhibited by a PKA inhibitor and a calmodulin kinase inhibitor, and is more abundant in cells at early log phase.","method":"Western blot (phosphorylation state), in vitro PKA phosphorylation of recombinant RTP/NDRG1, PKA inhibitor treatment, cAMP elevation, calmodulin kinase inhibitor","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus cellular pharmacological validation; single lab","pmids":["10860807"],"is_preprint":false},{"year":2000,"finding":"Mutations in NDRG1 (premature termination codon at position 148) cause hereditary motor and sensory neuropathy-Lom (HMSNL/CMT4D); NDRG1 is expressed at particularly high levels in Schwann cells, implicating it in Schwann-cell signaling necessary for axonal survival.","method":"Positional cloning, genomic sequencing, mutation analysis, in situ hybridization and immunohistochemistry in peripheral nerve","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — disease-causing mutations identified by positional cloning with high-level Schwann cell expression validated; founding paper replicated clinically","pmids":["10831399"],"is_preprint":false},{"year":2000,"finding":"Drg-1/NDRG1 overexpression in metastatic colon cancer cells (SW620) induced morphological differentiation, up-regulated differentiation markers (alkaline phosphatase, CEA, E-cadherin), reduced in vitro Matrigel invasion, and suppressed in vivo liver metastases in nude mice, establishing it as a metastasis suppressor.","method":"Stable transfection, Matrigel invasion assay, nude mouse liver metastasis model, Western blot, differentiation marker assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function/gain-of-function with defined in vivo metastasis phenotype; replicated across multiple subsequent studies","pmids":["10676663"],"is_preprint":false},{"year":2001,"finding":"The C-terminal TRSRSHTSEG repeat region of Cap43/NDRG1 protein coordinates Ni(II) and Cu(II) ions; each 10-amino acid histidine-containing repeat independently binds one metal ion, forming square-planar 4N complexes at physiological-to-alkaline pH involving the imidazole nitrogen of histidine and three deprotonated backbone amide nitrogens.","method":"pH-metric titration, UV-VIS, EPR, CD, NMR spectroscopy with synthetic peptides modeling the Cap43 C-terminus","journal":"Journal of inorganic biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biophysical methods; replicated with 20- and 30-aa fragments in later papers","pmids":["11330481"],"is_preprint":false},{"year":2002,"finding":"NDRG1 protein localizes primarily to the cytoplasm in epithelial cells and is also associated with the cellular membrane and adherens junctions; electron microscopy confirmed association with the E-cadherin/catenin complex, suggesting a functional role in cell-cell adhesion.","method":"Immunohistochemistry (light and electron microscopy) on normal human tissues, subcellular localization","journal":"Histochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization by IHC/EM in diverse tissues; functional link to adherens junctions inferred","pmids":["12432451"],"is_preprint":false},{"year":2003,"finding":"VHL tumor suppressor specifically down-regulates Cap43/NDRG1 expression in renal cancer cells; promoter deletion analysis identified an Sp1 site in the -286 to -62 bp region as partly responsible for VHL-induced suppression, and Cap43 mRNA remains inducible by hypoxia or nickel only in VHL-positive cell lines.","method":"VHL transfection into 786-O cells, Cap43 promoter deletion/mutation reporter assays, Northern blot, immunostaining","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — promoter functional analysis plus gene expression in isogenic VHL-positive/-negative lines; single lab","pmids":["12767066"],"is_preprint":false},{"year":2003,"finding":"Xenopus NDRG1 (xNDRG1) is required for pronephros development; morpholino-mediated depletion causes failure of pronephros development, and overexpression results in a reduced pronephros and disorganized somites, demonstrating a conserved developmental role.","method":"Morpholino antisense knockdown, mRNA overexpression, whole-mount in situ hybridization in Xenopus laevis embryos","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function in a vertebrate model organism with defined developmental phenotype; single lab","pmids":["12943662"],"is_preprint":false},{"year":2003,"finding":"The cellular distribution of NDRG1 protein changes during postnatal development in rat kidney (from proximal convoluted tubules to collecting ducts) and brain (from hippocampal pyramidal neurons to astrocytes) between postnatal days 10–20; concomitantly, NDRG1 shifts from a high-molecular-weight complex (~215 kDa under non-reducing conditions) to monomeric forms, suggesting developmental regulation of its assembly state.","method":"Immunohistochemistry, Western blot under reducing and non-reducing conditions across postnatal time points in rat","journal":"The journal of histochemistry and cytochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization with functional developmental context; single lab","pmids":["14566023"],"is_preprint":false},{"year":2004,"finding":"SGK1 phosphorylates NDRG1 at Thr328, Ser330, Thr346, Thr356, and Thr366 in vitro; these phosphorylations occur in vivo in multiple tissues of wild-type but not SGK1-knockout mice. SGK1-mediated phosphorylation of NDRG1 at Thr346 primes it for subsequent phosphorylation by GSK3 at Ser342, Ser352, and Ser362 in the GTRSRSHTSE decapeptide repeat region; GSK3 inhibition increases NDRG1 electrophoretic mobility in cells.","method":"In vitro kinase assays (SGK1, GSK3), mass spectrometry of phosphorylation sites, SGK1-knockout mouse tissues, siRNA knockdown of SGK1 in HeLa cells, GSK3 inhibitor CT99021","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with site identification by MS, validated in knockout mice and siRNA; multiple orthogonal approaches","pmids":["15461589"],"is_preprint":false},{"year":2004,"finding":"Iron chelation specifically up-regulates NDRG1 mRNA and protein expression through iron depletion; this induction is reversed by iron repletion, requires the iron-binding activity of the chelators (inactivated-binding-site chelator had no effect), correlates with their antiproliferative activity, and occurs via both HIF-1α-dependent and HIF-1α-independent transcriptional mechanisms.","method":"Gene array, Northern blot, Western blot, iron repletion experiments, HIF-1α pathway analysis, chelator Fe-complex controls","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple chelators, iron repletion controls, inactive-site control chelators, mechanistic pathway dissection; replicated by many subsequent studies","pmids":["15251988"],"is_preprint":false},{"year":2004,"finding":"Drg1/Rit42 (NDRG1) localizes to centrosomes and is a microtubule-associated protein; ectopic expression in p53-deficient tumor cells inhibited spindle-inhibitor-induced polyploidy and increased mitotic arrest, while siRNA knockdown in normal mammary epithelial cells caused disappearance of astral microtubules, defective spindle formation, and microtubule inhibitor-induced reduplication leading to polyploidy, establishing NDRG1 as a participant in the p53-dependent spindle checkpoint.","method":"Immunofluorescence/centrosome localization, ectopic expression, siRNA knockdown, flow cytometry (ploidy), spindle inhibitor treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function with defined mitotic phenotypes; single lab","pmids":["15247272"],"is_preprint":false},{"year":2004,"finding":"NDRG1 (Drg1) is markedly upregulated (~14-fold) by androgens in LNCaP prostate cancer cells; this induction reflects the altered specificity of the mutated androgen receptor in LNCaP cells and is absent in androgen receptor-negative tumor lines, identifying NDRG1 as an androgen-responsive gene.","method":"Differential display, Northern blot, androgen treatment, androgen receptor-negative cell line controls","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological induction with receptor-negative cell controls; single lab","pmids":["10428464"],"is_preprint":false},{"year":2006,"finding":"Cap43/NDRG1 overexpression in pancreatic cancer cells did not alter in vitro growth but markedly suppressed in vivo tumor growth by reducing tumor-induced angiogenesis; mechanistically, Cap43 overexpression decreased expression of MMP-9, VEGF, and IL-8, and reduced gelatinolytic/invasive activity.","method":"Stable transfection, xenograft tumor growth, Matrigel invasion, gelatin zymography, Western blot for MMP-9/VEGF/IL-8","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo gain-of-function with multiple molecular readouts; single lab","pmids":["16778198"],"is_preprint":false},{"year":2009,"finding":"Ndrg1 is a T-cell clonal anergy factor induced by Egr2: Ndrg1 overexpression mimics the anergic state, and knockout prevents anergy induction; Ndrg1 is phosphorylated and degraded via the proteasome upon CD28 co-stimulation, explaining why co-stimulation prevents anergy; IL-2 treatment of anergic T cells similarly induces Ndrg1 phosphorylation and degradation, reversing anergy.","method":"Overexpression, conditional knockout (Ndrg1-KO mice), proteasome inhibitor treatment, phosphorylation assays, T-cell anergy induction models, autoimmune inflammation assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function, knockout, and biochemical phosphorylation/degradation studies with multiple orthogonal approaches in vivo and in vitro","pmids":["26507712"],"is_preprint":false},{"year":2011,"finding":"NDRG1 phosphorylation by SGK1 is temporally and spatially controlled during the cell cycle: phosphorylated NDRG1 co-localizes with γ-tubulin at centromeres and at the cleavage furrow during cytokinesis; p53 deficiency increases basal NDRG1 expression and SGK1-mediated phosphorylation.","method":"Immunofluorescence co-localization with γ-tubulin, cell cycle synchronization (aphidicolin/nocodazole), Western blot in p53-proficient and -deficient HCT116 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization with functional cell cycle context; single lab","pmids":["21708134"],"is_preprint":false},{"year":2011,"finding":"Total Ndrg1 deficiency in the stretcher mouse model causes demyelinating neuropathy with onset between postnatal weeks 3 and 5 coinciding with rapid myelin growth; even low-level Ndrg1 expression provides significant phenotypic rescue; impaired Schwann cell trafficking (not growth arrest, differentiation, or proteasomal dysfunction) emerges as the likely pathogenic mechanism.","method":"Ndrg1-null (stretcher) and hypomorphic knockout mouse characterization, morphological/histological analysis, gene expression profiling, proteasomal function assays","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 — two mouse models with epistatic comparison; single lab","pmids":["21303696"],"is_preprint":false},{"year":2013,"finding":"NDRG1 silencing in epithelial cells reduces LDL receptor (LDLR) abundance at the plasma membrane by causing LDLR accumulation in enlarged EEA1-positive endosomes with increased LDLR ubiquitylation; co-depletion of IDOL (the E3 ligase that ubiquitylates LDLR) rescues plasma membrane LDLR and LDL uptake. In murine oligodendrocytes, Ndrg1 silencing reduces LDL uptake and downregulates Olig2, both rescued by Idol co-silencing. This establishes NDRG1 as a regulator of multivesicular body formation and endosomal LDLR trafficking.","method":"siRNA knockdown, co-depletion epistasis, immunofluorescence (EEA1/LDLR co-localization), LDL uptake assay, ubiquitylation assay, ESCRT protein Western blot","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — epistasis experiments with co-depletion, multiple cell types, multiple readouts; single lab but rigorous","pmids":["23813961"],"is_preprint":false},{"year":2013,"finding":"NDRG1 binds and stabilizes MGMT (O6-methylguanine-DNA methyltransferase) protein; this interaction confers MGMT-dependent resistance to alkylating chemotherapy in glioblastoma, driven by hypoxia, irradiation, corticosteroids, and chronic alkylating agent exposure via HIF-1α, p53, and mTORC2/SGK1 pathways.","method":"Co-immunoprecipitation (NDRG1-MGMT interaction), NDRG1 siRNA knockdown, mTOR pathway inhibition, posttreatment tumor tissue analysis, drug resistance assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of interaction, functional KD with resistance phenotype, multiple induction mechanisms tested; replicated in patient tissue","pmids":["24367102"],"is_preprint":false},{"year":2015,"finding":"NDRG1 physically associates with γ-tubulin (a key centrosome component) and mediates centrosome homeostasis downstream of p53: NDRG1 expression is induced by p53 under physiologic low-proliferative conditions, and loss of NDRG1 (by RNAi) causes centrosome amplification; TP53 null cells fail to increase NDRG1 and show aberrant centrosome numbers. TP53 homozygous loss was mutually exclusive with NDRG1 overexpression in >96% of human cancers.","method":"Co-immunoprecipitation (NDRG1-γ-tubulin), RNAi knockdown, overexpression, centrosome counting, isogenic TP53 wild-type/null/R248W cell lines, cancer genomics analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — Co-IP of NDRG1-γ-tubulin, functional KD/OE with centrosome phenotype, isogenic system, validated in cancer genomics","pmids":["26324937"],"is_preprint":false},{"year":2015,"finding":"SUMO-2 modification of NDRG1 at Lys14 regulates its protein stability: a SUMO-2-fused NDRG1 K14R mutant shows dramatically decreased protein stability compared to wild-type or the K14R SUMO-acceptor mutant alone; SUMO-2 modification does not affect NDRG1 subcellular distribution but reduces p21 expression when fused SUMO-2 NDRG1 K14R is overexpressed.","method":"SUMO modification assay, site-directed mutagenesis (K14R), stability assays, subcellular fractionation, Western blot for p21","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — mutagenesis and stability assays with functional readout; single lab","pmids":["25712528"],"is_preprint":false},{"year":2016,"finding":"NDRG1 physically associates with TLE2 and β-catenin to activate the Wnt/β-catenin pathway in esophageal squamous cell carcinoma cells; NDRG1 overexpression decreases TLE2 expression and increases β-catenin, inducing EMT; RNAi-mediated knockdown of TLE2 phenocopied NDRG1 overexpression, while TLE2 overexpression blocked NDRG1-mediated Wnt activation.","method":"Co-immunoprecipitation (NDRG1-TLE2, NDRG1-β-catenin), stable lentiviral overexpression, RNAi, Western blot for EMT markers","journal":"Cancer biology & therapy","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP with epistasis (TLE2 OE/KD); single lab","pmids":["27414086"],"is_preprint":false},{"year":2017,"finding":"NDRG1 inhibits EGFR/HER2 heterodimer and HER2/HER3 heterodimer formation, and promotes EGFR degradation; iron depletion (via novel thiosemicarbazone chelators) increases NDRG1 expression which in turn attenuates ErbB receptor signaling.","method":"Co-immunoprecipitation (EGFR/HER2, HER2/HER3 dimerization), NDRG1 overexpression/knockdown, receptor degradation assays, iron chelator treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP dimerization assays with NDRG1 manipulation; single lab review/research","pmids":["28615452"],"is_preprint":false},{"year":2017,"finding":"SGK1-mediated phosphorylation of Ndrg1 is induced during adipogenesis and promotes adipocyte differentiation and function by inducing PPARγ expression; Ndrg1 is also required for C/EBPα phosphorylation during adipogenesis; mTORC2 activation (via SGK1) is upstream of Ndrg1 phosphorylation in this context.","method":"siRNA knockdown, overexpression, adipogenesis assays, Western blot (PPARγ, C/EBPα phosphorylation), mTORC2 inhibitor treatment","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — KD/OE with defined pathway (mTORC2-SGK1-NDRG1-PPARγ) and cellular phenotype; single lab","pmids":["28775290"],"is_preprint":false},{"year":2019,"finding":"NDRG1 modulates the three arms of the ER stress response: it increases expression of ER chaperones BiP, calreticulin, and calnexin; suppresses PERK; inhibits IRE1α; and increases cleavage of ATF6. In the presence of Dp44mT (an iron chelator that up-regulates NDRG1), NDRG1 markedly increases eIF2α activation, maintains ATF4 expression, elevates cytosolic Ca2+, activates CaMKII, and increases pro-apoptotic CHOP.","method":"NDRG1 overexpression/siRNA knockdown, Western blot for ER stress pathway components, Ca2+ measurement, Dp44mT treatment, anti-proliferation/migration assays","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 — systematic gain- and loss-of-function with multiple molecular pathway readouts; single lab","pmids":["30981813"],"is_preprint":false},{"year":2019,"finding":"NDRG1 and GSK3β form a bidirectional regulatory loop in glioblastoma: NDRG1 overexpression promotes proteasomal degradation of GSK3β, suppressing AKT/S6 and cell-cycle signaling; conversely, GSK3β phosphorylates serine and threonine residues in the C-terminal domain of NDRG1, limiting NDRG1 protein stability.","method":"NDRG1 overexpression/knockdown, GSK3β selective inhibitors, proteasome inhibitor, co-immunoprecipitation, site-directed analysis of NDRG1 C-terminal domain phosphorylation, in vitro/in vivo tumor models","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional regulation shown with multiple functional approaches; single lab","pmids":["31723002"],"is_preprint":false},{"year":2021,"finding":"NDRG1 directly regulates androgen receptor (AR) signaling in prostate cancer: NDRG1 promotes AR interaction with HSP90 (shown by Co-IP), which stabilizes AR while decreasing its androgen-mediated activation; NDRG1 suppresses AR phosphorylation (p-ARSer213, p-ARSer81), PSA expression, and AR transcriptional activity partly by reducing c-Jun phosphorylation and inhibiting the c-Jun-AR interaction. The CAP domain of NDRG1 is identified as vital for inhibition of AR activity.","method":"Co-immunoprecipitation (AR-HSP90, AR-c-Jun), NDRG1 overexpression/siRNA, domain deletion mutants, phosphorylation Western blots, PSA reporter assay, patient prostatectomy specimens","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, domain mutagenesis, multiple phosphorylation readouts, validated in patient specimens; single lab with multiple orthogonal approaches","pmids":["34785213"],"is_preprint":false},{"year":2021,"finding":"N-cadherin suppresses NDRG1 expression through a c-Jun/AR/DNMT1 complex that binds TRE elements in the NDRG1 promoter and induces DNA hypermethylation, establishing a mechanistic axis (N-cadherin→c-Jun→epigenetic suppression of NDRG1) that promotes EMT and castration-resistant prostate cancer progression.","method":"ChIP assay (c-Jun, AR, DNMT1 on NDRG1 promoter TRE region), bisulfite sequencing, co-immunoprecipitation, N-cadherin knockdown/overexpression, NDRG1 promoter methylation analysis","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and bisulfite sequencing with functional N-cadherin manipulation; single lab","pmids":["34512147"],"is_preprint":false},{"year":2022,"finding":"NDRG1 acts as a critical mediator of endothelial inflammation: NDRG1 interacts with nuclear receptor Nur77 and functionally inhibits Nur77 transcriptional activity as well as NF-κB transcriptional activity; NDRG1 knockdown substantially attenuates IL-1β- and TNF-α-induced cytokine/chemokine and adhesion molecule expression, and inhibits MAPK/c-Jun/AP-1 activation. Endothelial cell-specific NDRG1 knockout mice show attenuated neointima formation, atherosclerosis, and arterial thrombosis.","method":"Co-immunoprecipitation (NDRG1-Nur77), shRNA lentiviral knockdown, luciferase reporter assays (Nur77, NF-κB, AP-1), endothelial-specific conditional knockout mice, carotid artery ligation model, thrombosis model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — Co-IP with Nur77, in vivo conditional KO mouse models, multiple signaling readouts; robust in vivo validation","pmids":["36562299"],"is_preprint":false},{"year":2023,"finding":"Fasting-induced mTORC2 activation phosphorylates NDRG1 at Ser336, and phospho-NDRG1 engages with mitochondria to facilitate DRP1-independent mitochondrial fission and sustain respiratory sufficiency; a phosphorylation-deficient NDRG1Ser336Ala mutant fails to engage mitochondria or facilitate fission. mTORC2-phosphorylated NDRG1 cooperates with CDC42 and its effectors/regulators to orchestrate fission.","method":"Time-lapse live imaging, proteomics, siRNA screen, epistasis (Rictor KO, NDRG1Ser336Ala mutant, Cdc42-deficient cells), phospho-specific antibodies, DRP1-KO cells","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — live imaging, phospho-mutant epistasis, proteomics, genetic epistasis across multiple KO systems; multiple orthogonal methods","pmids":["37386153"],"is_preprint":false},{"year":2022,"finding":"In zebrafish, Ndrg1a binds to the sodium-potassium ATPase (NKA) pump under anoxia and is required for its degradation, thereby conserving ATP in the kidney and ionocytes during oxygen deprivation; sodium azide treatment (which increases lactate under normoxia) is sufficient to trigger NKA degradation in an Ndrg1a-dependent manner, placing Ndrg1a downstream of lactate signaling as a metabolic switch.","method":"Co-immunoprecipitation (Ndrg1a-NKA), ndrg1a mutant zebrafish, anoxia survival assays, kidney function assays, sodium azide treatment","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, genetic mutant, physiological phenotype in zebrafish ortholog; single lab","pmids":["36214665"],"is_preprint":false},{"year":2024,"finding":"NDRG1 activates MHC-I expression in pancreatic ductal adenocarcinoma cells by preventing ATG9A-dependent lysosomal-autophagy degradation of MHC-I; NDRG1 knockdown reduces MHC-I surface levels, while NDRG1 overexpression or pharmacological activation increases MHC-I, promotes CD8+ T cell infiltration and anti-tumor immunity, and overcomes resistance to immune checkpoint blockade in mouse PDAC models.","method":"Co-immunoprecipitation (NDRG1-ATG9A interaction), RNA sequencing, autophagy/proteasome inhibitors, orthotopic PDAC tumor models, flow cytometry (CD8+ T cells), multiplex immunofluorescence","journal":"Drug resistance updates","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, pathway inhibitors, in vivo tumor models; single lab","pmids":["38228036"],"is_preprint":false},{"year":2024,"finding":"NSUN6-mediated m5C modification of NDRG1 mRNA promotes NDRG1 mRNA stability via the m5C reader ALYREF, which binds specifically to m5C-labeled NDRG1 mRNA; elevated NDRG1 expression promotes homologous recombination-mediated DNA repair, conferring radioresistance in cervical cancer.","method":"m5C-seq, mRNA-seq, RNA immunoprecipitation (ALYREF-NDRG1 mRNA), NSUN6 knockdown/overexpression, CDX and 3D PDO models, LC-MS/MS quantification of m5C","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — integrative m5C-seq with RNA-IP validation; multiple models (cell lines, CDX, PDO); single lab","pmids":["38970106"],"is_preprint":false}],"current_model":"NDRG1 is a stress-responsive cytoplasmic protein (alpha/beta hydrolase fold, no catalytic site) whose expression is induced by iron depletion (via HIF-1α-dependent and -independent mechanisms), hypoxia, nickel/Ca2+, N-myc repression, androgens, and ER stress; it is phosphorylated sequentially by mTORC2-SGK1 (at Thr328/330/346/356/366) and then primed-GSK3 (at Ser342/352/362) in its C-terminal GTRSRSHTSE repeat region, with additional phosphorylation and proteasomal degradation triggered by CD28/IL-2 signaling; NDRG1 suppresses metastasis by inhibiting EGFR/HER2/HER3 dimerization, binding MGMT to confer alkylating-agent resistance, interacting with γ-tubulin to maintain centrosome homeostasis, binding Nur77/NF-κB to regulate endothelial inflammation, regulating endosomal LDLR trafficking via multivesicular body formation, promoting AR stabilization via HSP90 while inhibiting AR activation, facilitating mTORC2-Ser336-phosphorylation-dependent mitochondrial fission through cooperation with CDC42, and preventing ATG9A-dependent autophagy degradation of MHC-I in pancreatic cancer; mutations in NDRG1 cause CMT4D demyelinating neuropathy through impaired Schwann cell trafficking."},"narrative":{"teleology":[{"year":1996,"claim":"The initial identification of NDRG1 as a stress-responsive cytoplasmic protein induced by homocysteine, ER stress agents, and reducing conditions established it as a gene whose expression reports on cellular stress, but its function remained unknown.","evidence":"Differential display and Northern blot cloning from HUVECs treated with homocysteine, tunicamycin, and 2-mercaptoethanol","pmids":["8939898"],"confidence":"Medium","gaps":["No function assigned beyond stress responsiveness","Protein localization at the subcellular level not determined","Mechanism of transcriptional induction not identified"]},{"year":2000,"claim":"Positional cloning of NDRG1 as the causative gene for CMT4D (HMSNL) and its concurrent identification as a metastasis suppressor in colon cancer established two cardinal biological roles — peripheral nerve maintenance and tumor suppression — raising the question of what molecular function could unify them.","evidence":"Positional cloning and mutation analysis in HMSNL families; stable overexpression in SW620 cells with in vivo liver metastasis assay in nude mice","pmids":["10831399","10676663"],"confidence":"High","gaps":["Molecular mechanism of metastasis suppression unknown","How a cytoplasmic protein maintains Schwann cell myelination not addressed","Whether the two phenotypes share a common pathway unclear"]},{"year":2001,"claim":"Biophysical characterization of the C-terminal TRSRSHTSEG repeats revealed direct metal ion (Ni²⁺, Cu²⁺) coordination through histidine imidazole and deprotonated backbone amides, providing a structural basis for nickel-dependent induction and suggesting the repeat region serves as both a regulatory phosphorylation target and a metal-binding module.","evidence":"pH-metric titration, UV-VIS, EPR, CD, and NMR spectroscopy with synthetic decapeptide repeats","pmids":["11330481"],"confidence":"High","gaps":["Physiological relevance of metal binding in vivo not established","Whether metal binding competes with phosphorylation not tested"]},{"year":2004,"claim":"Identification of SGK1 as the kinase that phosphorylates NDRG1 at five threonine sites, priming subsequent GSK3 phosphorylation at three serine sites, placed NDRG1 squarely downstream of the PI3K–mTORC2–SGK1 axis and defined the first signaling pathway controlling its post-translational modification.","evidence":"In vitro kinase assays with mass spectrometry site identification, validated in SGK1-knockout mouse tissues, siRNA, and GSK3 inhibitor in cells","pmids":["15461589"],"confidence":"High","gaps":["Functional consequence of SGK1/GSK3 phosphorylation on NDRG1 activity not determined","Whether other kinases act on these sites in specific tissues unknown"]},{"year":2004,"claim":"Demonstration that iron chelation upregulates NDRG1 through both HIF-1α-dependent and -independent pathways, reversible by iron repletion, revealed iron as a master regulator of NDRG1 expression and connected NDRG1 to hypoxia and iron-metabolism signaling.","evidence":"Multiple iron chelators with inactive-binding-site controls, iron repletion, Northern/Western blot, and HIF-1α pathway dissection","pmids":["15251988"],"confidence":"High","gaps":["Direct transcription factor binding to NDRG1 promoter under iron depletion not mapped","Relative contribution of HIF-1α-dependent vs -independent pathways unresolved"]},{"year":2004,"claim":"Localization of NDRG1 to centrosomes and its requirement for proper spindle formation and astral microtubule maintenance linked NDRG1 to mitotic fidelity and the p53-dependent spindle checkpoint, offering the first mechanistic connection between NDRG1 and genomic stability.","evidence":"Immunofluorescence centrosome localization, siRNA knockdown causing spindle defects, overexpression restoring spindle-checkpoint arrest in p53-null cells","pmids":["15247272"],"confidence":"Medium","gaps":["Direct binding partner at centrosomes not identified at this stage","Whether centrosome role accounts for metastasis suppression unclear"]},{"year":2013,"claim":"Two studies established NDRG1 as a regulator of receptor trafficking and a stabilizer of DNA-repair protein MGMT: NDRG1 controls LDLR endosomal sorting by opposing IDOL-mediated ubiquitylation and multivesicular body targeting, while NDRG1–MGMT interaction confers alkylating-agent resistance in glioblastoma, demonstrating that NDRG1 functions through specific protein–protein interactions rather than enzymatic activity.","evidence":"siRNA epistasis (NDRG1/IDOL co-depletion) with LDLR plasma-membrane and ubiquitylation readouts; Co-IP of NDRG1–MGMT with functional drug-resistance assays","pmids":["23813961","24367102"],"confidence":"High","gaps":["Structural basis of NDRG1–MGMT and NDRG1–LDLR/ESCRT interactions not resolved","Whether LDLR trafficking role extends to other cargo receptors unknown"]},{"year":2015,"claim":"Identification of γ-tubulin as a direct NDRG1 binding partner resolved the centrosomal mechanism: NDRG1 maintains centrosome homeostasis downstream of p53, and its loss causes centrosome amplification, explaining NDRG1's role in genomic stability and mutual exclusivity with TP53 loss in cancers.","evidence":"Co-immunoprecipitation of NDRG1–γ-tubulin, RNAi and overexpression with centrosome counting, isogenic TP53 cell lines, cancer genomics","pmids":["26324937"],"confidence":"High","gaps":["Domain on NDRG1 mediating γ-tubulin binding not mapped","Whether phosphorylation state modulates centrosome engagement unknown"]},{"year":2015,"claim":"Discovery that NDRG1 is a T-cell clonal anergy factor induced by Egr2, degraded via phosphorylation and proteasome upon CD28/IL-2 signaling, expanded NDRG1's role beyond epithelial biology into adaptive immunity.","evidence":"Ndrg1 overexpression, conditional knockout mice, proteasome inhibitor treatment, T-cell anergy models","pmids":["26507712"],"confidence":"High","gaps":["Kinase responsible for CD28-triggered NDRG1 phosphorylation not identified","Whether NDRG1's trafficking function underpins anergy mechanism unknown"]},{"year":2022,"claim":"NDRG1 was shown to bind Nur77 and NF-κB to regulate endothelial inflammatory signaling; endothelial-specific NDRG1 knockout attenuated atherosclerosis, neointima formation, and arterial thrombosis, establishing NDRG1 as a pro-inflammatory mediator in endothelial cells — a role distinct from its tumor-suppressive function in epithelia.","evidence":"Co-IP of NDRG1–Nur77, endothelial-specific conditional knockout mice, carotid ligation and thrombosis models, luciferase reporters for NF-κB and AP-1","pmids":["36562299"],"confidence":"High","gaps":["Whether endothelial NDRG1 acts through the same trafficking mechanism as in epithelia not tested","Structural basis of NDRG1–Nur77 interaction unknown"]},{"year":2023,"claim":"Identification of mTORC2-mediated Ser336 phosphorylation as a signal that directs NDRG1 to mitochondria to drive DRP1-independent fission through cooperation with CDC42 provided the first direct organellar effector mechanism for phospho-NDRG1, linking nutrient sensing to mitochondrial dynamics.","evidence":"Live imaging, phospho-Ser336-specific antibodies, Rictor-KO and NDRG1-S336A epistasis, DRP1-KO cells, proteomics","pmids":["37386153"],"confidence":"High","gaps":["Structural basis of NDRG1–CDC42 cooperation at the mitochondrial surface not resolved","Whether this fission mechanism operates in Schwann cells relevant to CMT4D unknown"]},{"year":2024,"claim":"NDRG1 was found to prevent ATG9A-dependent autophagy-mediated degradation of MHC-I in pancreatic cancer, restoring antigen presentation and overcoming immune checkpoint blockade resistance, extending NDRG1's trafficking role to autophagy-mediated surface receptor regulation and anti-tumor immunity.","evidence":"Co-IP of NDRG1–ATG9A, orthotopic PDAC models, autophagy/proteasome inhibitors, flow cytometry for CD8⁺ T cells","pmids":["38228036"],"confidence":"Medium","gaps":["Whether NDRG1 broadly opposes selective autophagy of membrane receptors beyond MHC-I not tested","Direct interaction domain mapping not performed"]},{"year":null,"claim":"The unifying structural basis for NDRG1's diverse protein–protein interactions (γ-tubulin, MGMT, Nur77, ATG9A, AR-HSP90, CDC42) remains unresolved: no high-resolution structure of full-length NDRG1 or its complexes exists, and how its alpha/beta hydrolase fold, CAP domain, and C-terminal repeat region coordinately engage different partners in different cellular contexts is the central open question.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No crystal or cryo-EM structure of full-length NDRG1 or any of its complexes","How phosphorylation switches partner specificity is mechanistically undefined","Whether NDRG1's role in Schwann cell trafficking and its mitochondrial fission function share a common membrane-remodeling mechanism is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[19,20,21,28,33]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[24,27,30]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[13,21]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,7]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[13,17,21]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[19]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[31]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,24,25,27,30,31]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[13,17,21]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[33]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,2,12,26]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,33]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[19,32]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,18]}],"complexes":[],"partners":["TUBG1","SGK1","GSK3B","MGMT","NR4A1","ATG9A","AR","CDC42"],"other_free_text":[]},"mechanistic_narrative":"NDRG1 is a stress-responsive, non-catalytic alpha/beta hydrolase-fold protein that functions as a scaffold integrating signal transduction, vesicular trafficking, and organelle homeostasis in response to iron depletion, hypoxia, and other cellular stresses. Its C-terminal GTRSRSHTSE decapeptide repeats are sequentially phosphorylated by mTORC2–SGK1 (Thr328/330/346/356/366) and then GSK3 (Ser342/352/362), and mTORC2-dependent phosphorylation at Ser336 directs NDRG1 to mitochondria where it cooperates with CDC42 to drive DRP1-independent mitochondrial fission [PMID:15461589, PMID:37386153]. NDRG1 suppresses metastasis by inhibiting EGFR/HER2/HER3 heterodimerization and downstream receptor tyrosine kinase signaling, regulates endosomal LDLR trafficking through multivesicular body formation, maintains centrosome homeostasis via γ-tubulin interaction downstream of p53, and prevents ATG9A-dependent autophagic degradation of MHC-I to sustain anti-tumor immunity [PMID:28615452, PMID:23813961, PMID:26324937, PMID:38228036]. Loss-of-function mutations in NDRG1 cause CMT4D (hereditary motor and sensory neuropathy-Lom), a demyelinating neuropathy attributable to impaired Schwann cell vesicular trafficking [PMID:10831399, PMID:21303696]."},"prefetch_data":{"uniprot":{"accession":"Q92597","full_name":"Protein NDRG1","aliases":["Differentiation-related gene 1 protein","DRG-1","N-myc downstream-regulated gene 1 protein","Nickel-specific induction protein Cap43","Reducing agents and tunicamycin-responsive protein","RTP","Rit42"],"length_aa":394,"mass_kda":42.8,"function":"Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53-mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy","subcellular_location":"Cytoplasm, cytosol; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Nucleus; Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q92597/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NDRG1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"DRG1","ensg_id":"ENSG00000185721","cell_line_id":"CID001617","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"SLC7A5","stoichiometry":10.0},{"gene":"ATP1A1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001617","total_profiled":1310},"omim":[{"mim_id":"614463","title":"NMYC DOWNSTREAM-REGULATED GENE 4; NDRG4","url":"https://www.omim.org/entry/614463"},{"mim_id":"605273","title":"NMYC DOWNSTREAM-REGULATED GENE 3; NDRG3","url":"https://www.omim.org/entry/605273"},{"mim_id":"605272","title":"NMYC DOWNSTREAM-REGULATED GENE 2; NDRG2","url":"https://www.omim.org/entry/605272"},{"mim_id":"605262","title":"NMYC DOWNSTREAM-REGULATED GENE 1; NDRG1","url":"https://www.omim.org/entry/605262"},{"mim_id":"601455","title":"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4D; CMT4D","url":"https://www.omim.org/entry/601455"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Connecting piece","reliability":"Supported"},{"location":"Mid piece","reliability":"Supported"},{"location":"Principal piece","reliability":"Supported"},{"location":"End piece","reliability":"Supported"},{"location":"Microtubules","reliability":"Additional"},{"location":"Calyx","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NDRG1"},"hgnc":{"alias_symbol":["DRG1","RTP","TDD5","NDR1"],"prev_symbol":["CAP43"]},"alphafold":{"accession":"Q92597","domains":[{"cath_id":"3.40.50.1820","chopping":"33-313","consensus_level":"high","plddt":92.4352,"start":33,"end":313}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92597","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92597-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92597-F1-predicted_aligned_error_v6.png","plddt_mean":78.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NDRG1","jax_strain_url":"https://www.jax.org/strain/search?query=NDRG1"},"sequence":{"accession":"Q92597","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92597.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92597/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92597"}},"corpus_meta":[{"pmid":"9707643","id":"PMC_9707643","title":"Different requirements for EDS1 and NDR1 by disease resistance genes define at least two R gene-mediated signaling pathways in Arabidopsis.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9707643","citation_count":575,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15550249","id":"PMC_15550249","title":"RTP family members induce functional expression of mammalian odorant receptors.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15550249","citation_count":474,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9605764","id":"PMC_9605764","title":"Cap43, a novel gene specifically induced by Ni2+ compounds.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9605764","citation_count":211,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10381566","id":"PMC_10381566","title":"N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10381566","citation_count":178,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12432451","id":"PMC_12432451","title":"Expression of NDRG1, a differentiation-related gene, in human tissues.","date":"2002","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12432451","citation_count":173,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24367102","id":"PMC_24367102","title":"mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24367102","citation_count":152,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33526596","id":"PMC_33526596","title":"Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33526596","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16778198","id":"PMC_16778198","title":"Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16778198","citation_count":138,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22345509","id":"PMC_22345509","title":"SR1, a calmodulin-binding transcription factor, modulates plant defense and ethylene-induced senescence by directly regulating NDR1 and EIN3.","date":"2012","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22345509","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23671130","id":"PMC_23671130","title":"Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23671130","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15447649","id":"PMC_15447649","title":"Overexpression of the plasma membrane-localized NDR1 protein results in enhanced bacterial disease resistance in Arabidopsis thaliana.","date":"2004","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15447649","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19327996","id":"PMC_19327996","title":"MST2- and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes.","date":"2009","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/19327996","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17646390","id":"PMC_17646390","title":"Cytoplasmic recycling of 60S preribosomal factors depends on the AAA protein Drg1.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17646390","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10428464","id":"PMC_10428464","title":"The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10428464","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15067004","id":"PMC_15067004","title":"Human Mob proteins regulate the NDR1 and NDR2 serine-threonine kinases.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15067004","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23750037","id":"PMC_23750037","title":"The role of NDRG1 in the pathology and potential treatment of human cancers.","date":"2013","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23750037","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16941900","id":"PMC_16941900","title":"Early responses in the Arabidopsis-Verticillium longisporum pathosystem are dependent on NDR1, JA- and ET-associated signals via cytosolic NPR1 and RFO1.","date":"2006","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/16941900","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10860807","id":"PMC_10860807","title":"Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10860807","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31132412","id":"PMC_31132412","title":"Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer.","date":"2019","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31132412","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23813961","id":"PMC_23813961","title":"NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23813961","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12767066","id":"PMC_12767066","title":"Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells.","date":"2003","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12767066","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38081786","id":"PMC_38081786","title":"Fused-Ring Pyrrole-Based Near-Infrared Emissive Organic RTP Material for Persistent Afterglow Bioimaging.","date":"2023","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/38081786","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20551432","id":"PMC_20551432","title":"Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma.","date":"2010","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/20551432","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23185031","id":"PMC_23185031","title":"Rlp24 activates the AAA-ATPase Drg1 to initiate cytoplasmic pre-60S maturation.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23185031","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15867226","id":"PMC_15867226","title":"Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes.","date":"2005","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15867226","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36562299","id":"PMC_36562299","title":"NDRG1 Signaling Is Essential for Endothelial Inflammation and Vascular Remodeling.","date":"2022","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/36562299","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12059109","id":"PMC_12059109","title":"NHL25 and NHL3, two NDR1/HIN1-1ike genes in Arabidopsis thaliana with potential role(s) in plant defense.","date":"2002","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/12059109","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21303696","id":"PMC_21303696","title":"Ndrg1 in development and maintenance of the myelin sheath.","date":"2011","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/21303696","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19800102","id":"PMC_19800102","title":"N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.","date":"2009","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19800102","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15247272","id":"PMC_15247272","title":"Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15247272","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24371142","id":"PMC_24371142","title":"The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24371142","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23526365","id":"PMC_23526365","title":"HIF-1α up-regulates NDRG1 expression through binding to NDRG1 promoter, leading to proliferation of lung cancer A549 cells.","date":"2013","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23526365","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12419264","id":"PMC_12419264","title":"The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.","date":"2002","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12419264","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21758001","id":"PMC_21758001","title":"The role of NDR1 in pathogen perception and plant defense signaling.","date":"2011","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21758001","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15676025","id":"PMC_15676025","title":"Identification of DRG family regulatory proteins (DFRPs): specific regulation of DRG1 and DRG2.","date":"2005","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/15676025","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22481237","id":"PMC_22481237","title":"NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.","date":"2012","source":"Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22481237","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36497221","id":"PMC_36497221","title":"NDRG1 in Cancer: A Suppressor, Promoter, or Both?","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/36497221","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38970106","id":"PMC_38970106","title":"NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.","date":"2024","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38970106","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32266933","id":"PMC_32266933","title":"m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32266933","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28615452","id":"PMC_28615452","title":"Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28615452","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21708134","id":"PMC_21708134","title":"Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21708134","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34572031","id":"PMC_34572031","title":"The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34572031","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27414086","id":"PMC_27414086","title":"NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.","date":"2016","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27414086","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11330481","id":"PMC_11330481","title":"Ni(II) and Cu(II) binding with a 14-aminoacid sequence of Cap43 protein, TRSRSHTSEGTRSR.","date":"2001","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11330481","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34893874","id":"PMC_34893874","title":"NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.","date":"2022","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/34893874","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37386153","id":"PMC_37386153","title":"mTORC2-NDRG1-CDC42 axis couples fasting to mitochondrial fission.","date":"2023","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37386153","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28137909","id":"PMC_28137909","title":"NDR1-Dependent Regulation of Kindlin-3 Controls High-Affinity LFA-1 Binding and Immune Synapse Organization.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28137909","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26849212","id":"PMC_26849212","title":"Overexpression of the NDR1/HIN1-Like Gene NHL6 Modifies Seed Germination in Response to Abscisic Acid and Abiotic Stresses in Arabidopsis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26849212","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18022432","id":"PMC_18022432","title":"Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma.","date":"2007","source":"Journal of pediatric surgery","url":"https://pubmed.ncbi.nlm.nih.gov/18022432","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15582665","id":"PMC_15582665","title":"HIV-1 incorporates and proteolytically processes human NDR1 and NDR2 serine-threonine kinases.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/15582665","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12943662","id":"PMC_12943662","title":"Identification and characterization of Xenopus NDRG1.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12943662","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30922920","id":"PMC_30922920","title":"Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30922920","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26507712","id":"PMC_26507712","title":"Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26507712","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14566023","id":"PMC_14566023","title":"Cellular distribution of NDRG1 protein in the rat kidney and brain during normal postnatal development.","date":"2003","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/14566023","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28216640","id":"PMC_28216640","title":"The ubiquitin ligase Cullin5SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28216640","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25081069","id":"PMC_25081069","title":"MicroRNA-769-3p down-regulates NDRG1 and enhances apoptosis in MCF-7 cells during reoxygenation.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25081069","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32165297","id":"PMC_32165297","title":"Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32165297","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24372490","id":"PMC_24372490","title":"Soybean NDR1-like proteins bind pathogen effectors and regulate resistance signaling.","date":"2013","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/24372490","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31723002","id":"PMC_31723002","title":"Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31723002","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24747552","id":"PMC_24747552","title":"Constitutively active NDR1-PIF kinase functions independent of MST1 and hMOB1 signalling.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24747552","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11224562","id":"PMC_11224562","title":"Structure of the RTP-DNA complex and the mechanism of polar replication fork arrest.","date":"2001","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/11224562","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26324937","id":"PMC_26324937","title":"NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26324937","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35459269","id":"PMC_35459269","title":"HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35459269","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34785213","id":"PMC_34785213","title":"The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34785213","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18985244","id":"PMC_18985244","title":"Copper(II) binding to Cap43 protein fragments.","date":"2008","source":"Dalton transactions (Cambridge, England : 2003)","url":"https://pubmed.ncbi.nlm.nih.gov/18985244","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26713269","id":"PMC_26713269","title":"Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43.","date":"2015","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/26713269","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30018336","id":"PMC_30018336","title":"Downregulated NDR1 protein kinase inhibits innate immune response by initiating an miR146a-STAT1 feedback loop.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30018336","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28775290","id":"PMC_28775290","title":"Ndrg1 promotes adipocyte differentiation and sustains their function.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28775290","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19587996","id":"PMC_19587996","title":"An NMR study on nickel binding sites in Cap43 protein fragments.","date":"2009","source":"Dalton transactions (Cambridge, England : 2003)","url":"https://pubmed.ncbi.nlm.nih.gov/19587996","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33586843","id":"PMC_33586843","title":"The Phytophthora effector Avh241 interacts with host NDR1-like proteins to manipulate plant immunity.","date":"2021","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/33586843","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22434109","id":"PMC_22434109","title":"RAMP like proteins : RTP and REEP family of proteins.","date":"2012","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/22434109","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23899187","id":"PMC_23899187","title":"Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.","date":"2013","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/23899187","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32265942","id":"PMC_32265942","title":"The Emerging Roles of NDR1/2 in Infection and Inflammation.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32265942","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18377423","id":"PMC_18377423","title":"Correlation between NDRG1 and PTEN expression in endometrial carcinoma.","date":"2008","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/18377423","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32106831","id":"PMC_32106831","title":"GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32106831","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19819225","id":"PMC_19819225","title":"Independent stabilizations of polysomal Drg1/Dfrp1 complex and non-polysomal Drg2/Dfrp2 complex in mammalian cells.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19819225","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26057687","id":"PMC_26057687","title":"Regulation of NDR1 activity by PLK1 ensures proper spindle orientation in mitosis.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26057687","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21775055","id":"PMC_21775055","title":"N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.","date":"2011","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21775055","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30981813","id":"PMC_30981813","title":"The metastasis suppressor, NDRG1, differentially modulates the endoplasmic reticulum stress response.","date":"2019","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30981813","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19760510","id":"PMC_19760510","title":"NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia.","date":"2009","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19760510","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28855639","id":"PMC_28855639","title":"Developmentally Regulated GTP binding protein 1 (DRG1) controls microtubule dynamics.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28855639","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36908010","id":"PMC_36908010","title":"CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.","date":"2023","source":"Small methods","url":"https://pubmed.ncbi.nlm.nih.gov/36908010","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29524631","id":"PMC_29524631","title":"HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29524631","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32557341","id":"PMC_32557341","title":"LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32557341","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36841367","id":"PMC_36841367","title":"The role of the NDRG1 in the pathogenesis and treatment of breast cancer.","date":"2023","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36841367","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25912875","id":"PMC_25912875","title":"NDR1 modulates the UV-induced DNA-damage checkpoint and nucleotide excision repair.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25912875","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29303911","id":"PMC_29303911","title":"Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer.","date":"2018","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/29303911","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15149799","id":"PMC_15149799","title":"Nickel(II) binding to Cap43 protein fragments.","date":"2004","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15149799","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25712528","id":"PMC_25712528","title":"SUMO modification regulates the protein stability of NDRG1.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25712528","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10064700","id":"PMC_10064700","title":"Site-directed mutants of RTP of Bacillus subtilis and the mechanism of replication fork arrest.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10064700","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34512147","id":"PMC_34512147","title":"The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer.","date":"2021","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34512147","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28292472","id":"PMC_28292472","title":"Increased NDRG1 expression attenuate trophoblast invasion through ERK/MMP-9 pathway in preeclampsia.","date":"2017","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/28292472","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38228036","id":"PMC_38228036","title":"NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.","date":"2024","source":"Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/38228036","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30443171","id":"PMC_30443171","title":"NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.","date":"2018","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30443171","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35488494","id":"PMC_35488494","title":"Overexpression of NDR1 leads to pathogen resistance at elevated temperatures.","date":"2022","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/35488494","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30497328","id":"PMC_30497328","title":"Different effects of long noncoding RNA NDRG1-OT1 fragments on NDRG1 transcription in breast cancer cells under hypoxia.","date":"2018","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/30497328","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36214665","id":"PMC_36214665","title":"N-myc downstream regulated gene 1 (ndrg1) functions as a molecular switch for cellular adaptation to hypoxia.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36214665","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22674419","id":"PMC_22674419","title":"NDR1/STK38 potentiates NF-κB activation by its kinase activity.","date":"2012","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/22674419","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37280098","id":"PMC_37280098","title":"The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics.","date":"2023","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/37280098","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35508987","id":"PMC_35508987","title":"NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.","date":"2022","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/35508987","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15302935","id":"PMC_15302935","title":"Large-scale characterization of HeLa cell nuclear phosphoproteins.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15302935","citation_count":1159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26638075","id":"PMC_26638075","title":"A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26638075","citation_count":433,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19402821","id":"PMC_19402821","title":"Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19402821","citation_count":395,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8939898","id":"PMC_8939898","title":"Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8939898","citation_count":317,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10831399","id":"PMC_10831399","title":"N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10831399","citation_count":298,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15461589","id":"PMC_15461589","title":"Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15461589","citation_count":296,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10676663","id":"PMC_10676663","title":"Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10676663","citation_count":285,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15251988","id":"PMC_15251988","title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15251988","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49563,"output_tokens":7008,"usd":0.126905},"stage2":{"model":"claude-opus-4-6","input_tokens":10736,"output_tokens":4220,"usd":0.23877},"total_usd":0.774818,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62017,"output_tokens":9462,"usd":0.163991},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":13592,"output_tokens":3819,"usd":0.245152}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"NDRG1 (Cap43) gene expression is specifically induced by Ni2+ compounds through elevation of free intracellular Ca2+ caused by Ni2+ exposure; calcium ionophores mimic induction and intracellular Ca2+ chelation attenuates it. Okadaic acid (serine/threonine phosphatase inhibitor) also induces Cap43, implicating phosphatase activity in its regulation.\",\n      \"method\": \"mRNA differential display, pharmacological manipulation (calcium ionophores, BAPTA-AM chelator, okadaic acid), in vitro cell exposure assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological interventions in cell lines, single lab\",\n      \"pmids\": [\"9605764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"N-myc (and c-myc) directly represses Ndrg1 promoter activity in a histone deacetylase-dependent manner (sensitive to Trichostatin A); repression is mediated by the promoter region within 52 bp of the transcription start site and is enhanced by N-myc:Max complex.\",\n      \"method\": \"Promoter-reporter cotransfection assay, Trichostatin A treatment, cDNA subtraction between wild-type and N-myc-deficient mouse embryos\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional assays with mutagenesis, single lab\",\n      \"pmids\": [\"10381566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NDRG1/RTP is a phosphoprotein phosphorylated at seven or more sites; phosphorylation is enhanced by elevated intracellular cAMP and inhibited by protein kinase A (PKA) inhibitor and calmodulin kinase inhibitor; PKA directly phosphorylates recombinant RTP in vitro.\",\n      \"method\": \"Western blot, in vitro kinase assay with recombinant protein, pharmacological inhibitors of PKA and calmodulin kinase\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus cellular pharmacology, single lab\",\n      \"pmids\": [\"10860807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal 10-amino acid repeat (TRSRSHTSEG) of Cap43/NDRG1 constitutes a Ni(II) and Cu(II) binding site; Ni(II) forms a square planar 4N complex via the histidine imidazole nitrogen and three deprotonated amide nitrogens; Cu(II) forms octahedral and square-planar complexes via similar coordination.\",\n      \"method\": \"pH-metric titration, UV-VIS, EPR, CD, and NMR spectroscopy of synthetic peptide fragments\",\n      \"journal\": \"Journal of inorganic biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal spectroscopic methods on defined peptide sequences, replicated across follow-up papers\",\n      \"pmids\": [\"11330481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NDRG1 protein localizes primarily to the cytoplasm but is also associated with the cell membrane and adherens junctions in epithelial cells; nuclear localization is observed under hypoxia, suggesting a role in protection from ischemic cell damage.\",\n      \"method\": \"Immunohistochemistry at light and electron microscopy levels in a large panel of normal human tissues\",\n      \"journal\": \"Histochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by electron and light microscopy, but no functional rescue experiment\",\n      \"pmids\": [\"12432451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"VHL tumor suppressor downregulates Cap43/NDRG1 expression; Cap43 promoter assays with deletion/mutation constructs identified an Sp1 site in the -286 to -62 bp element as partly responsible for VHL-induced suppression.\",\n      \"method\": \"Stable VHL transfection into VHL-negative renal cancer cells, promoter deletion/mutation reporter assays\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter mutagenesis plus gain-of-function cell line comparison, single lab\",\n      \"pmids\": [\"12767066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In Xenopus laevis, NDRG1 (xNDRG1) is required for pronephros development; morpholino-mediated depletion causes failure of pronephros development, and overexpression causes reduced pronephros and disorganized somites.\",\n      \"method\": \"Xenopus overexpression and morpholino knockdown with phenotypic analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function in Xenopus with defined phenotypic readout, single lab\",\n      \"pmids\": [\"12943662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NDRG1/Rit42 protein is a microtubule-associated protein that localizes to centrosomes; ectopic expression inhibits polyploidy in p53-deficient cells exposed to spindle inhibitors, and siRNA knockdown in normal cells abolishes astral microtubules and leads to microtubule inhibitor-induced polyploidy, indicating a role in the spindle checkpoint dependent on p53.\",\n      \"method\": \"Ectopic expression in p53-null tumor lines, siRNA knockdown in normal mammary epithelial cells, immunofluorescence localization, flow cytometry for ploidy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — both gain- and loss-of-function with cellular phenotype, single lab\",\n      \"pmids\": [\"15247272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DRG1 (NDRG1-related GTPase, distinct from NDRG1 per se) is stabilized by its specific binding partner DFRP1; DFRP1 blocks poly-ubiquitination and proteasomal degradation of DRG1 in the cytoplasm. [Note: This concerns the GTP-binding protein DRG1/DFRP1 complex distinct from NDRG1 metastasis suppressor.]\",\n      \"method\": \"Transient transfection, co-immunoprecipitation, DFRP1 knockout cell line, immunofluorescence\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — pertains to GTPase DRG1, not NDRG1 metastasis suppressor; symbol collision risk\",\n      \"pmids\": [\"15676025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NDRG1/Cap43 overexpression in pancreatic cancer cells decreases MMP-9 gelatinolytic activity, invasive ability, and expression of VEGF and IL-8 (angiogenic factors), leading to markedly reduced tumor-induced angiogenesis in vivo without affecting in vitro growth rates.\",\n      \"method\": \"Stable cDNA transfection, Matrigel invasion assay, gelatin zymography, VEGF/IL-8 ELISA, in vivo xenograft tumor growth and angiogenesis assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mechanistic assays in vitro and in vivo, single lab\",\n      \"pmids\": [\"16778198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NDRG1 phosphorylation by SGK1 is temporally and spatially regulated during the cell cycle; phosphorylated NDRG1 co-localizes with γ-tubulin on centromeres and at the cleavage furrow during cytokinesis, suggesting a role in mitosis.\",\n      \"method\": \"Cell cycle synchronization (aphidicolin, nocodazole), immunofluorescence co-localization with γ-tubulin, isogenic p53-proficient and -deficient HCT116 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiments tied to cell cycle stages with functional implication, single lab\",\n      \"pmids\": [\"21708134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Total Ndrg1 deficiency in mice causes demyelination in large peripheral nerve fibers coinciding with rapid growth and myelin volume expansion, while small fibers remain unaffected; the phenotype is more severe than a hypomorphic knockout, indicating dose-dependence. Impaired Schwann cell trafficking is proposed as the pathogenetic mechanism.\",\n      \"method\": \"Mouse genetic model (stretcher Ndrg1 null vs. hypomorphic KO), peripheral nerve histopathology, gene expression profiling, myelin morphometry\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — well-characterized mouse knockout with defined tissue phenotype, single lab\",\n      \"pmids\": [\"21303696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG1 bound and stabilized MGMT (O6-methylguanine-DNA methyltransferase) protein, conferring resistance to alkylating chemotherapy; NDRG1 expression is induced by hypoxia via HIF-1α, by p53, and by the mTORC2/SGK1 pathway.\",\n      \"method\": \"Co-immunoprecipitation of NDRG1-MGMT interaction, siRNA knockdown, pharmacological mTOR pathway manipulation, post-treatment tumor tissue analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus genetic knockdown with functional drug resistance readout, replicated in patient tissue\",\n      \"pmids\": [\"24367102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG1 silencing in epithelial cells reduces LDL receptor (LDLR) abundance at the plasma membrane, causes LDLR accumulation in enlarged EEA1-positive endosomes with increased LDLR ubiquitylation, and downregulates ESCRT proteins. Co-depletion of IDOL (LDLR ubiquitin ligase) rescues plasma membrane LDLR levels, identifying NDRG1 as a regulator of multivesicular body formation and endosomal LDLR trafficking.\",\n      \"method\": \"siRNA silencing, immunofluorescence, flow cytometry for LDL uptake, ubiquitylation assay, rescue by IDOL co-depletion in HeLa and mouse oligodendrocytes\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (genetic rescue, ubiquitylation, imaging), strong mechanistic detail, single lab\",\n      \"pmids\": [\"23813961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG1 physically associates with γ-tubulin at the centrosome and this association is reduced in p53-null cells. NDRG1 regulates centrosome number; its overexpression reduces centrosome amplification and knockdown increases it. TP53 homozygous loss is mutually exclusive of NDRG1 overexpression in >96% of human cancers.\",\n      \"method\": \"Co-immunoprecipitation of NDRG1 with γ-tubulin, immunofluorescence, RNAi knockdown and overexpression in isogenic TP53 WT/null/R248W cell lines, cancer genomics analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — Co-IP plus loss/gain-of-function with centrosome phenotype, orthogonal genomics validation\",\n      \"pmids\": [\"26324937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Ndrg1 is induced by the transcription factor Egr2 during T-cell anergy signaling. Ndrg1 is phosphorylated and degraded via the proteasome upon CD28 co-stimulation or IL-2 treatment. Knockout of Ndrg1 prevents anergy induction and Ndrg1-deficient mice show T-cell hyperresponsiveness.\",\n      \"method\": \"Egr2-driven reporter assay, Ndrg1 knockout mice, overexpression in T cells, proteasome inhibitor rescue, phosphorylation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO mouse with immune phenotype, proteasome-dependent degradation mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"26507712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG1 is posttranslationally modified by SUMO-2 preferentially at Lys14; SUMO-2 modification at this site influences NDRG1 protein stability, and a SUMO-2-fused NDRG1 K14R mutant shows dramatically decreased protein stability and reduced p21 expression.\",\n      \"method\": \"SUMO modification assay, site-directed mutagenesis (K14R), overexpression of SUMO-2 fused constructs, western blot for p21 and stability\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of modification site with functional stability readout, single lab\",\n      \"pmids\": [\"25712528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NDRG1 physically associates with TLE2 and β-catenin, thereby activating Wnt signaling and inducing EMT in esophageal squamous cell carcinoma; NDRG1 overexpression decreases TLE2 expression while increasing β-catenin.\",\n      \"method\": \"Co-immunoprecipitation of NDRG1-TLE2 and NDRG1-β-catenin, stable lentiviral overexpression, RNAi, western blot for EMT markers\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional follow-up, single lab\",\n      \"pmids\": [\"27414086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDRG1 inhibits ErbB receptor signaling by inhibiting formation of EGFR/HER2 and HER2/HER3 heterodimers and by promoting EGFR degradation.\",\n      \"method\": \"Co-immunoprecipitation of receptor heterodimers, siRNA knockdown and overexpression, degradation assays in cancer cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of receptor dimers with gain/loss-of-function, single lab\",\n      \"pmids\": [\"28615452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Ndrg1 promotes adipocyte differentiation by inducing PPARγ expression; Sgk1-dependent phosphorylation of Ndrg1 is required for adipocyte formation and is induced downstream of mTORC2. Ndrg1 is also required for C/EBPα phosphorylation during adipogenesis.\",\n      \"method\": \"Ndrg1 siRNA knockdown and overexpression in preadipocytes, phosphomutant constructs, western blot for PPARγ, C/EBPα phosphorylation, lipid staining\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined differentiation phenotype plus phosphomutant analysis, single lab\",\n      \"pmids\": [\"28775290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDRG1 regulates all three arms of the ER stress response: increasing ER chaperones (BiP, calreticulin, calnexin), suppressing PERK and IRE1α arms, and increasing ATF6 cleavage. NDRG1 expression enhances eIF2α phosphorylation, ATF4 maintenance, CaMKII signaling, and CHOP expression when combined with Dp44mT.\",\n      \"method\": \"siRNA knockdown and stable overexpression in pancreatic and colon cancer cells, western blot for ER stress markers, Ca2+ measurements, cell migration/proliferation assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple ER stress pathway readouts with gain/loss of function, single lab\",\n      \"pmids\": [\"30981813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDRG1 and GSK3β negatively regulate each other: NDRG1 overexpression suppresses GBM cell growth by promoting proteasomal degradation of GSK3β and suppressing AKT/S6 signaling; conversely, GSK3β phosphorylates serine and threonine residues in the C-terminal domain of NDRG1, limiting NDRG1 protein stability.\",\n      \"method\": \"siRNA knockdown, stable overexpression, GSK3β-selective inhibitors, proteasome inhibitor rescue, western blot for NDRG1 phosphorylation, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional regulation demonstrated with pharmacological and genetic approaches, in vitro and in vivo, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31723002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NDRG1 promotes interaction of the androgen receptor (AR) with HSP90, stabilizing AR while decreasing its androgen-mediated activation; NDRG1 suppresses AR phosphorylation (Ser213, Ser81), PSA expression, and AR transcriptional activity, partly by reducing c-Jun phosphorylation (Ser63) to inhibit the c-Jun-AR interaction. The CAP domain of NDRG1 is vital for inhibition of AR activity.\",\n      \"method\": \"Co-immunoprecipitation (AR-HSP90), siRNA knockdown and overexpression in multiple PCa cell lines, domain deletion/mutagenesis, luciferase reporter for AR transcription, western blot for phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus domain mutagenesis plus multiple functional readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34785213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NDRG1 interacts with the orphan nuclear receptor Nur77 and functionally inhibits Nur77 and NF-κB transcriptional activity in endothelial cells; NDRG1 knockdown attenuates cytokine-induced MAPK/c-Jun/AP-1 signaling, adhesion molecule expression, and procoagulant molecule expression. Endothelial-specific NDRG1 knockout mice show attenuated neointima formation, atherosclerosis, and arterial thrombosis.\",\n      \"method\": \"Co-immunoprecipitation of NDRG1-Nur77, shRNA knockdown via lentivirus, endothelial-specific NDRG1 KO mouse model, carotid artery ligation and thrombosis models, NF-κB/AP-1 reporter assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, in vivo KO mouse with vascular phenotype, multiple pathway readouts, single lab\",\n      \"pmids\": [\"36562299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"mTORC2 phosphorylates NDRG1 at serine 336 during fasting/lipid availability; phosphorylated NDRG1 engages with mitochondria to facilitate DRP1-independent mitochondrial fission and respiratory sufficiency. NDRG1 cooperates with small GTPase CDC42 and its effectors/regulators to orchestrate fission; NDRG1-S336A phosphorylation-deficient mutant fails to rescue fission in cells lacking DRP1.\",\n      \"method\": \"mTORC2 conditional KO (Rictor KO), phospho-specific NDRG1-S336 analysis, NDRG1-S336A phosphomutant, time-lapse live imaging of mitochondria, siRNA screen, epistasis experiments with CDC42\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phosphomutant reconstitution, live imaging, genetic epistasis, proteomics, multiple orthogonal methods in single study\",\n      \"pmids\": [\"37386153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NSUN6 methyltransferase promotes m5C modification of NDRG1 mRNA; the m5C reader ALYREF specifically binds m5C-labeled NDRG1 mRNA and enhances NDRG1 mRNA stability, upregulating NDRG1 protein. Elevated NDRG1 promotes homologous recombination-mediated DNA repair, contributing to radioresistance in cervical cancer.\",\n      \"method\": \"Integrated m5C-seq and mRNA-seq, RNA immunoprecipitation (RIP), NSUN6 overexpression/silencing in cell lines and PDO models, siRNA knockdown of ALYREF, in vivo CDX model\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — integrated multi-omics with RIP validation, functional in vivo confirmation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38970106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NDRG1 inhibits ATG9A-dependent lysosomal-autophagy degradation of MHC class I (MHC-1) in pancreatic ductal adenocarcinoma cells; NDRG1 overexpression stabilizes MHC-1 surface expression, promotes CD8+ T cell infiltration and activity, and overcomes resistance to immune checkpoint blockade.\",\n      \"method\": \"Co-immunoprecipitation and immunolocalization of NDRG1-ATG9A-MHC-1, lysosomal/proteasomal inhibitor treatment, orthotopic tumor models, flow cytometry for CD8+ T cells, multiplex immunofluorescence\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with pathway inhibitor rescue, in vivo tumor model, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"38228036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish, Ndrg1a binds to the Na+/K+-ATPase (NKA) pump under anoxia and is required for NKA degradation in kidney and ionocytes; sodium azide treatment (lactate signaling mimic) triggers NKA degradation in an Ndrg1a-dependent manner, conserving cellular energy during hypoxia.\",\n      \"method\": \"Ndrg1a mutant zebrafish, co-immunoprecipitation of Ndrg1a-NKA, pharmacological anoxia/sodium azide treatment, kidney function assays, survival analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus genetic KO with defined physiological phenotype in zebrafish ortholog, single lab\",\n      \"pmids\": [\"36214665\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDRG1 is a stress-responsive, phosphorylatable cytoplasmic/nuclear protein that acts as a metastasis suppressor and signaling hub: it is transcriptionally repressed by N-Myc via histone deacetylase-dependent mechanisms and induced by hypoxia (via HIF-1α), Ni2+/Ca2+, p53, and mTORC2/SGK1; mTORC2 phosphorylates NDRG1 at Ser336 to drive mitochondrial fission via CDC42; NDRG1 suppresses oncogenic signaling by disrupting EGFR/HER2/HER3 receptor heterodimers, stabilizing AR-HSP90 to attenuate androgen receptor activation, inhibiting NF-κB and Nur77 in endothelial cells, promoting proteasomal degradation of GSK3β, stabilizing MGMT to confer alkylating agent resistance, regulating endosomal LDLR trafficking by controlling multivesicular body formation, maintaining centrosome homeostasis via γ-tubulin association, protecting MHC-I from ATG9A-dependent autophagic degradation, and sustaining T-cell anergy as an Egr2 target that is phosphorylated and proteasomally degraded upon CD28 co-stimulation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Cap43 (NDRG1) mRNA is specifically induced by nickel compounds (Ni3S2 or NiCl2) via elevation of free intracellular Ca2+, as demonstrated by induction with calcium ionophores and attenuation by intracellular Ca2+ chelation; induction is not mimicked by oxidative stress or heat shock, and okadaic acid (a serine/threonine phosphatase inhibitor) induces Cap43 more strongly than nickel, implicating phosphatase-regulated signaling in its regulation.\",\n      \"method\": \"mRNA differential display, calcium ionophore treatment, intracellular Ca2+ chelation with BAPTA-AM, okadaic acid treatment, Northern blot in human and rodent cells\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pharmacological manipulations in a single lab; specific induction mechanism via Ca2+ established\",\n      \"pmids\": [\"9605764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ndrg1 is transcriptionally repressed by N-myc: N-myc (and c-myc) together with Max down-regulate the Ndrg1 promoter through a region within 52 bp of the transcription start site, and this repression requires histone deacetylase activity (sensitive to Trichostatin A); direct binding of N-myc:Max to the promoter was not demonstrated, analogous to indirect repression mechanisms reported for c-myc targets.\",\n      \"method\": \"Promoter-reporter cotransfection assay, Trichostatin A treatment, whole-embryo cDNA subtraction in N-myc-deficient mice, in situ hybridization\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional promoter deletion assays with pharmacological validation; single lab\",\n      \"pmids\": [\"10381566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"NDRG1 (originally named RTP) was first identified as a homocysteine-responsive gene product in vascular endothelial cells, also induced by 2-mercaptoethanol and tunicamycin (ER stress inducers), establishing it as a stress-responsive cytoplasmic protein.\",\n      \"method\": \"Differential display, Northern blot, full-length cDNA cloning from HUVEC library\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — original cloning with multiple stress inducers tested; single lab\",\n      \"pmids\": [\"8939898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NDRG1 is phosphorylated by protein kinase A (PKA) at multiple sites (seven or more) in vitro and in cells; phosphorylation is reversible, enhanced by elevated intracellular cAMP, inhibited by a PKA inhibitor and a calmodulin kinase inhibitor, and is more abundant in cells at early log phase.\",\n      \"method\": \"Western blot (phosphorylation state), in vitro PKA phosphorylation of recombinant RTP/NDRG1, PKA inhibitor treatment, cAMP elevation, calmodulin kinase inhibitor\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus cellular pharmacological validation; single lab\",\n      \"pmids\": [\"10860807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Mutations in NDRG1 (premature termination codon at position 148) cause hereditary motor and sensory neuropathy-Lom (HMSNL/CMT4D); NDRG1 is expressed at particularly high levels in Schwann cells, implicating it in Schwann-cell signaling necessary for axonal survival.\",\n      \"method\": \"Positional cloning, genomic sequencing, mutation analysis, in situ hybridization and immunohistochemistry in peripheral nerve\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — disease-causing mutations identified by positional cloning with high-level Schwann cell expression validated; founding paper replicated clinically\",\n      \"pmids\": [\"10831399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Drg-1/NDRG1 overexpression in metastatic colon cancer cells (SW620) induced morphological differentiation, up-regulated differentiation markers (alkaline phosphatase, CEA, E-cadherin), reduced in vitro Matrigel invasion, and suppressed in vivo liver metastases in nude mice, establishing it as a metastasis suppressor.\",\n      \"method\": \"Stable transfection, Matrigel invasion assay, nude mouse liver metastasis model, Western blot, differentiation marker assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function/gain-of-function with defined in vivo metastasis phenotype; replicated across multiple subsequent studies\",\n      \"pmids\": [\"10676663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The C-terminal TRSRSHTSEG repeat region of Cap43/NDRG1 protein coordinates Ni(II) and Cu(II) ions; each 10-amino acid histidine-containing repeat independently binds one metal ion, forming square-planar 4N complexes at physiological-to-alkaline pH involving the imidazole nitrogen of histidine and three deprotonated backbone amide nitrogens.\",\n      \"method\": \"pH-metric titration, UV-VIS, EPR, CD, NMR spectroscopy with synthetic peptides modeling the Cap43 C-terminus\",\n      \"journal\": \"Journal of inorganic biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical methods; replicated with 20- and 30-aa fragments in later papers\",\n      \"pmids\": [\"11330481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NDRG1 protein localizes primarily to the cytoplasm in epithelial cells and is also associated with the cellular membrane and adherens junctions; electron microscopy confirmed association with the E-cadherin/catenin complex, suggesting a functional role in cell-cell adhesion.\",\n      \"method\": \"Immunohistochemistry (light and electron microscopy) on normal human tissues, subcellular localization\",\n      \"journal\": \"Histochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by IHC/EM in diverse tissues; functional link to adherens junctions inferred\",\n      \"pmids\": [\"12432451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"VHL tumor suppressor specifically down-regulates Cap43/NDRG1 expression in renal cancer cells; promoter deletion analysis identified an Sp1 site in the -286 to -62 bp region as partly responsible for VHL-induced suppression, and Cap43 mRNA remains inducible by hypoxia or nickel only in VHL-positive cell lines.\",\n      \"method\": \"VHL transfection into 786-O cells, Cap43 promoter deletion/mutation reporter assays, Northern blot, immunostaining\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional analysis plus gene expression in isogenic VHL-positive/-negative lines; single lab\",\n      \"pmids\": [\"12767066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Xenopus NDRG1 (xNDRG1) is required for pronephros development; morpholino-mediated depletion causes failure of pronephros development, and overexpression results in a reduced pronephros and disorganized somites, demonstrating a conserved developmental role.\",\n      \"method\": \"Morpholino antisense knockdown, mRNA overexpression, whole-mount in situ hybridization in Xenopus laevis embryos\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function in a vertebrate model organism with defined developmental phenotype; single lab\",\n      \"pmids\": [\"12943662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The cellular distribution of NDRG1 protein changes during postnatal development in rat kidney (from proximal convoluted tubules to collecting ducts) and brain (from hippocampal pyramidal neurons to astrocytes) between postnatal days 10–20; concomitantly, NDRG1 shifts from a high-molecular-weight complex (~215 kDa under non-reducing conditions) to monomeric forms, suggesting developmental regulation of its assembly state.\",\n      \"method\": \"Immunohistochemistry, Western blot under reducing and non-reducing conditions across postnatal time points in rat\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization with functional developmental context; single lab\",\n      \"pmids\": [\"14566023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SGK1 phosphorylates NDRG1 at Thr328, Ser330, Thr346, Thr356, and Thr366 in vitro; these phosphorylations occur in vivo in multiple tissues of wild-type but not SGK1-knockout mice. SGK1-mediated phosphorylation of NDRG1 at Thr346 primes it for subsequent phosphorylation by GSK3 at Ser342, Ser352, and Ser362 in the GTRSRSHTSE decapeptide repeat region; GSK3 inhibition increases NDRG1 electrophoretic mobility in cells.\",\n      \"method\": \"In vitro kinase assays (SGK1, GSK3), mass spectrometry of phosphorylation sites, SGK1-knockout mouse tissues, siRNA knockdown of SGK1 in HeLa cells, GSK3 inhibitor CT99021\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with site identification by MS, validated in knockout mice and siRNA; multiple orthogonal approaches\",\n      \"pmids\": [\"15461589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Iron chelation specifically up-regulates NDRG1 mRNA and protein expression through iron depletion; this induction is reversed by iron repletion, requires the iron-binding activity of the chelators (inactivated-binding-site chelator had no effect), correlates with their antiproliferative activity, and occurs via both HIF-1α-dependent and HIF-1α-independent transcriptional mechanisms.\",\n      \"method\": \"Gene array, Northern blot, Western blot, iron repletion experiments, HIF-1α pathway analysis, chelator Fe-complex controls\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple chelators, iron repletion controls, inactive-site control chelators, mechanistic pathway dissection; replicated by many subsequent studies\",\n      \"pmids\": [\"15251988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Drg1/Rit42 (NDRG1) localizes to centrosomes and is a microtubule-associated protein; ectopic expression in p53-deficient tumor cells inhibited spindle-inhibitor-induced polyploidy and increased mitotic arrest, while siRNA knockdown in normal mammary epithelial cells caused disappearance of astral microtubules, defective spindle formation, and microtubule inhibitor-induced reduplication leading to polyploidy, establishing NDRG1 as a participant in the p53-dependent spindle checkpoint.\",\n      \"method\": \"Immunofluorescence/centrosome localization, ectopic expression, siRNA knockdown, flow cytometry (ploidy), spindle inhibitor treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function with defined mitotic phenotypes; single lab\",\n      \"pmids\": [\"15247272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NDRG1 (Drg1) is markedly upregulated (~14-fold) by androgens in LNCaP prostate cancer cells; this induction reflects the altered specificity of the mutated androgen receptor in LNCaP cells and is absent in androgen receptor-negative tumor lines, identifying NDRG1 as an androgen-responsive gene.\",\n      \"method\": \"Differential display, Northern blot, androgen treatment, androgen receptor-negative cell line controls\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological induction with receptor-negative cell controls; single lab\",\n      \"pmids\": [\"10428464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Cap43/NDRG1 overexpression in pancreatic cancer cells did not alter in vitro growth but markedly suppressed in vivo tumor growth by reducing tumor-induced angiogenesis; mechanistically, Cap43 overexpression decreased expression of MMP-9, VEGF, and IL-8, and reduced gelatinolytic/invasive activity.\",\n      \"method\": \"Stable transfection, xenograft tumor growth, Matrigel invasion, gelatin zymography, Western blot for MMP-9/VEGF/IL-8\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo gain-of-function with multiple molecular readouts; single lab\",\n      \"pmids\": [\"16778198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ndrg1 is a T-cell clonal anergy factor induced by Egr2: Ndrg1 overexpression mimics the anergic state, and knockout prevents anergy induction; Ndrg1 is phosphorylated and degraded via the proteasome upon CD28 co-stimulation, explaining why co-stimulation prevents anergy; IL-2 treatment of anergic T cells similarly induces Ndrg1 phosphorylation and degradation, reversing anergy.\",\n      \"method\": \"Overexpression, conditional knockout (Ndrg1-KO mice), proteasome inhibitor treatment, phosphorylation assays, T-cell anergy induction models, autoimmune inflammation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function, knockout, and biochemical phosphorylation/degradation studies with multiple orthogonal approaches in vivo and in vitro\",\n      \"pmids\": [\"26507712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NDRG1 phosphorylation by SGK1 is temporally and spatially controlled during the cell cycle: phosphorylated NDRG1 co-localizes with γ-tubulin at centromeres and at the cleavage furrow during cytokinesis; p53 deficiency increases basal NDRG1 expression and SGK1-mediated phosphorylation.\",\n      \"method\": \"Immunofluorescence co-localization with γ-tubulin, cell cycle synchronization (aphidicolin/nocodazole), Western blot in p53-proficient and -deficient HCT116 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization with functional cell cycle context; single lab\",\n      \"pmids\": [\"21708134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Total Ndrg1 deficiency in the stretcher mouse model causes demyelinating neuropathy with onset between postnatal weeks 3 and 5 coinciding with rapid myelin growth; even low-level Ndrg1 expression provides significant phenotypic rescue; impaired Schwann cell trafficking (not growth arrest, differentiation, or proteasomal dysfunction) emerges as the likely pathogenic mechanism.\",\n      \"method\": \"Ndrg1-null (stretcher) and hypomorphic knockout mouse characterization, morphological/histological analysis, gene expression profiling, proteasomal function assays\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two mouse models with epistatic comparison; single lab\",\n      \"pmids\": [\"21303696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG1 silencing in epithelial cells reduces LDL receptor (LDLR) abundance at the plasma membrane by causing LDLR accumulation in enlarged EEA1-positive endosomes with increased LDLR ubiquitylation; co-depletion of IDOL (the E3 ligase that ubiquitylates LDLR) rescues plasma membrane LDLR and LDL uptake. In murine oligodendrocytes, Ndrg1 silencing reduces LDL uptake and downregulates Olig2, both rescued by Idol co-silencing. This establishes NDRG1 as a regulator of multivesicular body formation and endosomal LDLR trafficking.\",\n      \"method\": \"siRNA knockdown, co-depletion epistasis, immunofluorescence (EEA1/LDLR co-localization), LDL uptake assay, ubiquitylation assay, ESCRT protein Western blot\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis experiments with co-depletion, multiple cell types, multiple readouts; single lab but rigorous\",\n      \"pmids\": [\"23813961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NDRG1 binds and stabilizes MGMT (O6-methylguanine-DNA methyltransferase) protein; this interaction confers MGMT-dependent resistance to alkylating chemotherapy in glioblastoma, driven by hypoxia, irradiation, corticosteroids, and chronic alkylating agent exposure via HIF-1α, p53, and mTORC2/SGK1 pathways.\",\n      \"method\": \"Co-immunoprecipitation (NDRG1-MGMT interaction), NDRG1 siRNA knockdown, mTOR pathway inhibition, posttreatment tumor tissue analysis, drug resistance assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of interaction, functional KD with resistance phenotype, multiple induction mechanisms tested; replicated in patient tissue\",\n      \"pmids\": [\"24367102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NDRG1 physically associates with γ-tubulin (a key centrosome component) and mediates centrosome homeostasis downstream of p53: NDRG1 expression is induced by p53 under physiologic low-proliferative conditions, and loss of NDRG1 (by RNAi) causes centrosome amplification; TP53 null cells fail to increase NDRG1 and show aberrant centrosome numbers. TP53 homozygous loss was mutually exclusive with NDRG1 overexpression in >96% of human cancers.\",\n      \"method\": \"Co-immunoprecipitation (NDRG1-γ-tubulin), RNAi knockdown, overexpression, centrosome counting, isogenic TP53 wild-type/null/R248W cell lines, cancer genomics analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — Co-IP of NDRG1-γ-tubulin, functional KD/OE with centrosome phenotype, isogenic system, validated in cancer genomics\",\n      \"pmids\": [\"26324937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SUMO-2 modification of NDRG1 at Lys14 regulates its protein stability: a SUMO-2-fused NDRG1 K14R mutant shows dramatically decreased protein stability compared to wild-type or the K14R SUMO-acceptor mutant alone; SUMO-2 modification does not affect NDRG1 subcellular distribution but reduces p21 expression when fused SUMO-2 NDRG1 K14R is overexpressed.\",\n      \"method\": \"SUMO modification assay, site-directed mutagenesis (K14R), stability assays, subcellular fractionation, Western blot for p21\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — mutagenesis and stability assays with functional readout; single lab\",\n      \"pmids\": [\"25712528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NDRG1 physically associates with TLE2 and β-catenin to activate the Wnt/β-catenin pathway in esophageal squamous cell carcinoma cells; NDRG1 overexpression decreases TLE2 expression and increases β-catenin, inducing EMT; RNAi-mediated knockdown of TLE2 phenocopied NDRG1 overexpression, while TLE2 overexpression blocked NDRG1-mediated Wnt activation.\",\n      \"method\": \"Co-immunoprecipitation (NDRG1-TLE2, NDRG1-β-catenin), stable lentiviral overexpression, RNAi, Western blot for EMT markers\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with epistasis (TLE2 OE/KD); single lab\",\n      \"pmids\": [\"27414086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDRG1 inhibits EGFR/HER2 heterodimer and HER2/HER3 heterodimer formation, and promotes EGFR degradation; iron depletion (via novel thiosemicarbazone chelators) increases NDRG1 expression which in turn attenuates ErbB receptor signaling.\",\n      \"method\": \"Co-immunoprecipitation (EGFR/HER2, HER2/HER3 dimerization), NDRG1 overexpression/knockdown, receptor degradation assays, iron chelator treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP dimerization assays with NDRG1 manipulation; single lab review/research\",\n      \"pmids\": [\"28615452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SGK1-mediated phosphorylation of Ndrg1 is induced during adipogenesis and promotes adipocyte differentiation and function by inducing PPARγ expression; Ndrg1 is also required for C/EBPα phosphorylation during adipogenesis; mTORC2 activation (via SGK1) is upstream of Ndrg1 phosphorylation in this context.\",\n      \"method\": \"siRNA knockdown, overexpression, adipogenesis assays, Western blot (PPARγ, C/EBPα phosphorylation), mTORC2 inhibitor treatment\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD/OE with defined pathway (mTORC2-SGK1-NDRG1-PPARγ) and cellular phenotype; single lab\",\n      \"pmids\": [\"28775290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDRG1 modulates the three arms of the ER stress response: it increases expression of ER chaperones BiP, calreticulin, and calnexin; suppresses PERK; inhibits IRE1α; and increases cleavage of ATF6. In the presence of Dp44mT (an iron chelator that up-regulates NDRG1), NDRG1 markedly increases eIF2α activation, maintains ATF4 expression, elevates cytosolic Ca2+, activates CaMKII, and increases pro-apoptotic CHOP.\",\n      \"method\": \"NDRG1 overexpression/siRNA knockdown, Western blot for ER stress pathway components, Ca2+ measurement, Dp44mT treatment, anti-proliferation/migration assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic gain- and loss-of-function with multiple molecular pathway readouts; single lab\",\n      \"pmids\": [\"30981813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NDRG1 and GSK3β form a bidirectional regulatory loop in glioblastoma: NDRG1 overexpression promotes proteasomal degradation of GSK3β, suppressing AKT/S6 and cell-cycle signaling; conversely, GSK3β phosphorylates serine and threonine residues in the C-terminal domain of NDRG1, limiting NDRG1 protein stability.\",\n      \"method\": \"NDRG1 overexpression/knockdown, GSK3β selective inhibitors, proteasome inhibitor, co-immunoprecipitation, site-directed analysis of NDRG1 C-terminal domain phosphorylation, in vitro/in vivo tumor models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional regulation shown with multiple functional approaches; single lab\",\n      \"pmids\": [\"31723002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NDRG1 directly regulates androgen receptor (AR) signaling in prostate cancer: NDRG1 promotes AR interaction with HSP90 (shown by Co-IP), which stabilizes AR while decreasing its androgen-mediated activation; NDRG1 suppresses AR phosphorylation (p-ARSer213, p-ARSer81), PSA expression, and AR transcriptional activity partly by reducing c-Jun phosphorylation and inhibiting the c-Jun-AR interaction. The CAP domain of NDRG1 is identified as vital for inhibition of AR activity.\",\n      \"method\": \"Co-immunoprecipitation (AR-HSP90, AR-c-Jun), NDRG1 overexpression/siRNA, domain deletion mutants, phosphorylation Western blots, PSA reporter assay, patient prostatectomy specimens\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, domain mutagenesis, multiple phosphorylation readouts, validated in patient specimens; single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"34785213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"N-cadherin suppresses NDRG1 expression through a c-Jun/AR/DNMT1 complex that binds TRE elements in the NDRG1 promoter and induces DNA hypermethylation, establishing a mechanistic axis (N-cadherin→c-Jun→epigenetic suppression of NDRG1) that promotes EMT and castration-resistant prostate cancer progression.\",\n      \"method\": \"ChIP assay (c-Jun, AR, DNMT1 on NDRG1 promoter TRE region), bisulfite sequencing, co-immunoprecipitation, N-cadherin knockdown/overexpression, NDRG1 promoter methylation analysis\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and bisulfite sequencing with functional N-cadherin manipulation; single lab\",\n      \"pmids\": [\"34512147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NDRG1 acts as a critical mediator of endothelial inflammation: NDRG1 interacts with nuclear receptor Nur77 and functionally inhibits Nur77 transcriptional activity as well as NF-κB transcriptional activity; NDRG1 knockdown substantially attenuates IL-1β- and TNF-α-induced cytokine/chemokine and adhesion molecule expression, and inhibits MAPK/c-Jun/AP-1 activation. Endothelial cell-specific NDRG1 knockout mice show attenuated neointima formation, atherosclerosis, and arterial thrombosis.\",\n      \"method\": \"Co-immunoprecipitation (NDRG1-Nur77), shRNA lentiviral knockdown, luciferase reporter assays (Nur77, NF-κB, AP-1), endothelial-specific conditional knockout mice, carotid artery ligation model, thrombosis model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with Nur77, in vivo conditional KO mouse models, multiple signaling readouts; robust in vivo validation\",\n      \"pmids\": [\"36562299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Fasting-induced mTORC2 activation phosphorylates NDRG1 at Ser336, and phospho-NDRG1 engages with mitochondria to facilitate DRP1-independent mitochondrial fission and sustain respiratory sufficiency; a phosphorylation-deficient NDRG1Ser336Ala mutant fails to engage mitochondria or facilitate fission. mTORC2-phosphorylated NDRG1 cooperates with CDC42 and its effectors/regulators to orchestrate fission.\",\n      \"method\": \"Time-lapse live imaging, proteomics, siRNA screen, epistasis (Rictor KO, NDRG1Ser336Ala mutant, Cdc42-deficient cells), phospho-specific antibodies, DRP1-KO cells\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — live imaging, phospho-mutant epistasis, proteomics, genetic epistasis across multiple KO systems; multiple orthogonal methods\",\n      \"pmids\": [\"37386153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish, Ndrg1a binds to the sodium-potassium ATPase (NKA) pump under anoxia and is required for its degradation, thereby conserving ATP in the kidney and ionocytes during oxygen deprivation; sodium azide treatment (which increases lactate under normoxia) is sufficient to trigger NKA degradation in an Ndrg1a-dependent manner, placing Ndrg1a downstream of lactate signaling as a metabolic switch.\",\n      \"method\": \"Co-immunoprecipitation (Ndrg1a-NKA), ndrg1a mutant zebrafish, anoxia survival assays, kidney function assays, sodium azide treatment\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, genetic mutant, physiological phenotype in zebrafish ortholog; single lab\",\n      \"pmids\": [\"36214665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NDRG1 activates MHC-I expression in pancreatic ductal adenocarcinoma cells by preventing ATG9A-dependent lysosomal-autophagy degradation of MHC-I; NDRG1 knockdown reduces MHC-I surface levels, while NDRG1 overexpression or pharmacological activation increases MHC-I, promotes CD8+ T cell infiltration and anti-tumor immunity, and overcomes resistance to immune checkpoint blockade in mouse PDAC models.\",\n      \"method\": \"Co-immunoprecipitation (NDRG1-ATG9A interaction), RNA sequencing, autophagy/proteasome inhibitors, orthotopic PDAC tumor models, flow cytometry (CD8+ T cells), multiplex immunofluorescence\",\n      \"journal\": \"Drug resistance updates\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, pathway inhibitors, in vivo tumor models; single lab\",\n      \"pmids\": [\"38228036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NSUN6-mediated m5C modification of NDRG1 mRNA promotes NDRG1 mRNA stability via the m5C reader ALYREF, which binds specifically to m5C-labeled NDRG1 mRNA; elevated NDRG1 expression promotes homologous recombination-mediated DNA repair, conferring radioresistance in cervical cancer.\",\n      \"method\": \"m5C-seq, mRNA-seq, RNA immunoprecipitation (ALYREF-NDRG1 mRNA), NSUN6 knockdown/overexpression, CDX and 3D PDO models, LC-MS/MS quantification of m5C\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — integrative m5C-seq with RNA-IP validation; multiple models (cell lines, CDX, PDO); single lab\",\n      \"pmids\": [\"38970106\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NDRG1 is a stress-responsive cytoplasmic protein (alpha/beta hydrolase fold, no catalytic site) whose expression is induced by iron depletion (via HIF-1α-dependent and -independent mechanisms), hypoxia, nickel/Ca2+, N-myc repression, androgens, and ER stress; it is phosphorylated sequentially by mTORC2-SGK1 (at Thr328/330/346/356/366) and then primed-GSK3 (at Ser342/352/362) in its C-terminal GTRSRSHTSE repeat region, with additional phosphorylation and proteasomal degradation triggered by CD28/IL-2 signaling; NDRG1 suppresses metastasis by inhibiting EGFR/HER2/HER3 dimerization, binding MGMT to confer alkylating-agent resistance, interacting with γ-tubulin to maintain centrosome homeostasis, binding Nur77/NF-κB to regulate endothelial inflammation, regulating endosomal LDLR trafficking via multivesicular body formation, promoting AR stabilization via HSP90 while inhibiting AR activation, facilitating mTORC2-Ser336-phosphorylation-dependent mitochondrial fission through cooperation with CDC42, and preventing ATG9A-dependent autophagy degradation of MHC-I in pancreatic cancer; mutations in NDRG1 cause CMT4D demyelinating neuropathy through impaired Schwann cell trafficking.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NDRG1 is a stress-responsive, multiply phosphorylated cytoplasmic scaffold protein that integrates nutrient, hypoxia, and immune signals to regulate membrane receptor trafficking, centrosome homeostasis, mitochondrial dynamics, and metastasis suppression. It is transcriptionally induced by HIF-1α, p53, and Egr2, repressed by N-Myc via HDAC-dependent mechanisms, and post-translationally regulated by SGK1/mTORC2 phosphorylation at Ser336, GSK3β-mediated phosphorylation, SUMO-2 conjugation at Lys14, and proteasomal degradation upon CD28 co-stimulation [PMID:10381566, PMID:37386153, PMID:31723002, PMID:25712528, PMID:26507712]. Mechanistically, NDRG1 suppresses oncogenic signaling by disrupting EGFR/HER2/HER3 heterodimers, stabilizing AR–HSP90 complexes to attenuate androgen receptor activation, promoting proteasomal degradation of GSK3β, regulating endosomal LDLR trafficking through ESCRT-dependent multivesicular body formation, and protecting MHC class I from ATG9A-mediated autophagic degradation [PMID:28615452, PMID:34785213, PMID:31723002, PMID:23813961, PMID:38228036]. Upon mTORC2-dependent Ser336 phosphorylation, NDRG1 engages CDC42 at mitochondria to drive DRP1-independent mitochondrial fission, associates with γ-tubulin to maintain centrosome number, and in T cells functions as an Egr2-induced anergy effector whose degradation upon co-stimulation licenses T-cell activation [PMID:37386153, PMID:26324937, PMID:26507712].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identifying that NDRG1 expression is induced by nickel through intracellular calcium elevation established it as a stress-responsive gene, opening the question of what signals regulate it.\",\n      \"evidence\": \"Pharmacological manipulation (calcium ionophores, BAPTA-AM, okadaic acid) in Ni²⁺-exposed cell lines\",\n      \"pmids\": [\"9605764\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream calcium-sensing mechanism not defined\", \"Relevance beyond nickel exposure unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that N-Myc directly represses the NDRG1 promoter via HDAC-dependent mechanisms linked NDRG1 to oncogene-driven transcriptional control and explained its loss in N-Myc-amplified cancers.\",\n      \"evidence\": \"Promoter-reporter assays with Trichostatin A and N-Myc:Max co-transfection in mouse embryo-derived system\",\n      \"pmids\": [\"10381566\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct N-Myc binding to the promoter not shown by ChIP\", \"Chromatin context not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showing that NDRG1 is phosphorylated at multiple sites by PKA and calmodulin kinase established it as a phospho-regulated protein, raising the question of which kinases are physiologically relevant.\",\n      \"evidence\": \"In vitro kinase assay with recombinant NDRG1, pharmacological inhibitors in cell culture\",\n      \"pmids\": [\"10860807\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific phosphosites not mapped\", \"Functional consequence of PKA phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Structural characterization of the C-terminal decapeptide repeat as a Ni(II)/Cu(II) coordination site provided a molecular basis for NDRG1's metal-binding capacity.\",\n      \"evidence\": \"Multi-spectroscopic analysis (pH-metric, UV-VIS, EPR, CD, NMR) of synthetic peptides\",\n      \"pmids\": [\"11330481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biological function of metal binding in vivo unknown\", \"Whether metal binding affects phosphorylation or protein interactions untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Immunolocalization revealed NDRG1 as primarily cytoplasmic with membrane/adherens junction association and hypoxia-induced nuclear translocation, framing it as a dynamically localized protein.\",\n      \"evidence\": \"Light and electron microscopy immunohistochemistry across a panel of normal human tissues\",\n      \"pmids\": [\"12432451\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear translocation mechanism not defined\", \"Functional significance of junctional localization untested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that NDRG1 localizes to centrosomes, associates with microtubules, and prevents spindle-inhibitor-induced polyploidy established its first defined cellular function in mitotic fidelity.\",\n      \"evidence\": \"Ectopic expression in p53-null lines, siRNA knockdown in normal mammary epithelial cells, immunofluorescence\",\n      \"pmids\": [\"15247272\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding partner at centrosome not identified at this stage\", \"Mechanism of polyploidy suppression unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that NDRG1 overexpression suppresses MMP-9 activity, VEGF/IL-8 secretion, and in vivo angiogenesis without affecting proliferation provided the first mechanistic evidence for its metastasis-suppressor function.\",\n      \"evidence\": \"Stable transfection in pancreatic cancer cells, Matrigel invasion, gelatin zymography, ELISA, xenograft angiogenesis\",\n      \"pmids\": [\"16778198\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target mediating MMP-9/VEGF suppression not identified\", \"Relevance to other cancer types untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two parallel advances — showing SGK1-phosphorylated NDRG1 co-localizes with γ-tubulin during mitosis, and that Ndrg1-null mice develop peripheral demyelination — connected NDRG1 phosphorylation to cell division and demonstrated its requirement for Schwann cell membrane trafficking in vivo.\",\n      \"evidence\": \"Cell cycle synchronization with immunofluorescence; Ndrg1-null mouse nerve histopathology and morphometry\",\n      \"pmids\": [\"21708134\", \"21303696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SGK1 phosphosite identity not mapped at this stage\", \"Schwann cell trafficking defect not molecularly characterized\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two studies revealed NDRG1's role in protein stabilization (MGMT) and membrane receptor trafficking (LDLR via ESCRT/multivesicular body regulation), establishing it as a pleiotropic scaffold controlling both DNA repair and endosomal sorting.\",\n      \"evidence\": \"Reciprocal Co-IP of NDRG1-MGMT with drug resistance readout; siRNA-mediated NDRG1 depletion with LDLR imaging, ubiquitylation assays, and IDOL co-depletion rescue\",\n      \"pmids\": [\"24367102\", \"23813961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of MGMT stabilization unknown\", \"Whether ESCRT regulation is direct or indirect unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Three discoveries consolidated NDRG1's functions: physical association with γ-tubulin controlling centrosome number, an immunological role as an Egr2-induced anergy effector degraded upon co-stimulation, and SUMO-2 modification at Lys14 regulating its stability.\",\n      \"evidence\": \"Co-IP of NDRG1–γ-tubulin with centrosome counting in isogenic TP53 lines; Ndrg1 KO mice with T-cell hyperresponsiveness; SUMO-2 modification/mutagenesis assays\",\n      \"pmids\": [\"26324937\", \"26507712\", \"25712528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How p53 status controls NDRG1–γ-tubulin binding unknown\", \"Kinase responsible for anergy-associated phosphorylation not identified\", \"Interplay between SUMOylation and phosphorylation unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating that NDRG1 disrupts EGFR/HER2 and HER2/HER3 heterodimers and promotes EGFR degradation provided a direct receptor-level mechanism for its metastasis-suppressor activity.\",\n      \"evidence\": \"Co-IP of receptor heterodimers, siRNA knockdown and overexpression, degradation assays in cancer cell lines\",\n      \"pmids\": [\"28615452\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NDRG1 directly contacts ErbB receptors or acts through an adaptor unknown\", \"Structural mechanism of dimer disruption unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Bidirectional regulation between NDRG1 and GSK3β was established: NDRG1 promotes GSK3β proteasomal degradation while GSK3β phosphorylates NDRG1's C-terminus to reduce its stability, revealing a mutual antagonism controlling tumor growth.\",\n      \"evidence\": \"Reciprocal knockdown/overexpression, GSK3β inhibitors, proteasome inhibitor rescue, in vivo GBM xenograft models\",\n      \"pmids\": [\"31723002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ubiquitin ligase mediating GSK3β degradation not identified\", \"Specific GSK3β phosphosites on NDRG1 not fully mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing that NDRG1 stabilizes the AR–HSP90 complex while attenuating AR transcriptional activation via its CAP domain resolved how NDRG1 modulates androgen signaling in prostate cancer.\",\n      \"evidence\": \"Co-IP of AR–HSP90, domain deletion/mutagenesis, luciferase AR reporter, phospho-AR western blots in multiple PCa lines\",\n      \"pmids\": [\"34785213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NDRG1 directly contacts HSP90 or AR not resolved structurally\", \"In vivo prostate tumor model not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Two studies expanded NDRG1's roles to vascular inflammation and hypoxia-adaptive metabolism: NDRG1 inhibits Nur77/NF-κB in endothelial cells to control neointima formation and thrombosis, and zebrafish Ndrg1a mediates anoxia-triggered Na⁺/K⁺-ATPase degradation for energy conservation.\",\n      \"evidence\": \"Endothelial-specific NDRG1 KO mice with vascular phenotyping; Ndrg1a mutant zebrafish with Co-IP of Ndrg1a–NKA under anoxia\",\n      \"pmids\": [\"36562299\", \"36214665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Nur77 interaction is direct in structural terms unknown\", \"NKA degradation pathway (lysosomal vs proteasomal) not fully defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying mTORC2-dependent Ser336 phosphorylation as the trigger for NDRG1's recruitment to mitochondria, where it cooperates with CDC42 to drive DRP1-independent fission, revealed a novel mitochondrial fission pathway.\",\n      \"evidence\": \"Rictor KO cells, phospho-S336 analysis, S336A phosphomutant reconstitution, live imaging, CDC42 epistasis\",\n      \"pmids\": [\"37386153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NDRG1 is targeted to mitochondrial membranes mechanistically unknown\", \"Whether this pathway operates in non-fasting conditions unclear\", \"Structural basis of CDC42–NDRG1 cooperation not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two studies revealed upstream RNA-level regulation (NSUN6-mediated m5C modification stabilizing NDRG1 mRNA via ALYREF) and a new immune-evasion mechanism (NDRG1 protects MHC-I from ATG9A-dependent autophagic degradation), connecting NDRG1 to epitranscriptomic control and antitumor immunity.\",\n      \"evidence\": \"m5C-seq/RIP for NSUN6-ALYREF-NDRG1 mRNA axis with in vivo CDX model; Co-IP of NDRG1-ATG9A-MHC-I with orthotopic pancreatic tumor model and CD8⁺ T-cell analysis\",\n      \"pmids\": [\"38970106\", \"38228036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether m5C regulation is tissue-specific unknown\", \"Whether ATG9A interaction is direct or bridged by adaptors unresolved\", \"Integration of epitranscriptomic and post-translational regulation untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite extensive characterization of NDRG1's many binding partners and phosphorylation-dependent functions, no high-resolution structure of full-length NDRG1 or its complexes exists, leaving unclear how a single protein scaffolds such diverse interactions and how its multiple post-translational modifications (phosphorylation, SUMOylation, metal binding) are coordinated to specify pathway choice.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of NDRG1 or any NDRG1 complex\", \"No systematic mapping of mutually exclusive vs. cooperative post-translational modifications\", \"Tissue-specific functions not systematically compared\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [13, 14, 22, 24, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [18, 21, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 7]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [7, 10, 14]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 13]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [18, 21, 23, 24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7, 10, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15, 26]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TUBG1\",\n      \"GSK3B\",\n      \"AR\",\n      \"HSP90AA1\",\n      \"NR4A1\",\n      \"ATG9A\",\n      \"CDC42\",\n      \"MGMT\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NDRG1 is a stress-responsive, non-catalytic alpha/beta hydrolase-fold protein that functions as a scaffold integrating signal transduction, vesicular trafficking, and organelle homeostasis in response to iron depletion, hypoxia, and other cellular stresses. Its C-terminal GTRSRSHTSE decapeptide repeats are sequentially phosphorylated by mTORC2–SGK1 (Thr328/330/346/356/366) and then GSK3 (Ser342/352/362), and mTORC2-dependent phosphorylation at Ser336 directs NDRG1 to mitochondria where it cooperates with CDC42 to drive DRP1-independent mitochondrial fission [PMID:15461589, PMID:37386153]. NDRG1 suppresses metastasis by inhibiting EGFR/HER2/HER3 heterodimerization and downstream receptor tyrosine kinase signaling, regulates endosomal LDLR trafficking through multivesicular body formation, maintains centrosome homeostasis via γ-tubulin interaction downstream of p53, and prevents ATG9A-dependent autophagic degradation of MHC-I to sustain anti-tumor immunity [PMID:28615452, PMID:23813961, PMID:26324937, PMID:38228036]. Loss-of-function mutations in NDRG1 cause CMT4D (hereditary motor and sensory neuropathy-Lom), a demyelinating neuropathy attributable to impaired Schwann cell vesicular trafficking [PMID:10831399, PMID:21303696].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"The initial identification of NDRG1 as a stress-responsive cytoplasmic protein induced by homocysteine, ER stress agents, and reducing conditions established it as a gene whose expression reports on cellular stress, but its function remained unknown.\",\n      \"evidence\": \"Differential display and Northern blot cloning from HUVECs treated with homocysteine, tunicamycin, and 2-mercaptoethanol\",\n      \"pmids\": [\"8939898\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No function assigned beyond stress responsiveness\", \"Protein localization at the subcellular level not determined\", \"Mechanism of transcriptional induction not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Positional cloning of NDRG1 as the causative gene for CMT4D (HMSNL) and its concurrent identification as a metastasis suppressor in colon cancer established two cardinal biological roles — peripheral nerve maintenance and tumor suppression — raising the question of what molecular function could unify them.\",\n      \"evidence\": \"Positional cloning and mutation analysis in HMSNL families; stable overexpression in SW620 cells with in vivo liver metastasis assay in nude mice\",\n      \"pmids\": [\"10831399\", \"10676663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of metastasis suppression unknown\", \"How a cytoplasmic protein maintains Schwann cell myelination not addressed\", \"Whether the two phenotypes share a common pathway unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Biophysical characterization of the C-terminal TRSRSHTSEG repeats revealed direct metal ion (Ni²⁺, Cu²⁺) coordination through histidine imidazole and deprotonated backbone amides, providing a structural basis for nickel-dependent induction and suggesting the repeat region serves as both a regulatory phosphorylation target and a metal-binding module.\",\n      \"evidence\": \"pH-metric titration, UV-VIS, EPR, CD, and NMR spectroscopy with synthetic decapeptide repeats\",\n      \"pmids\": [\"11330481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of metal binding in vivo not established\", \"Whether metal binding competes with phosphorylation not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of SGK1 as the kinase that phosphorylates NDRG1 at five threonine sites, priming subsequent GSK3 phosphorylation at three serine sites, placed NDRG1 squarely downstream of the PI3K–mTORC2–SGK1 axis and defined the first signaling pathway controlling its post-translational modification.\",\n      \"evidence\": \"In vitro kinase assays with mass spectrometry site identification, validated in SGK1-knockout mouse tissues, siRNA, and GSK3 inhibitor in cells\",\n      \"pmids\": [\"15461589\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of SGK1/GSK3 phosphorylation on NDRG1 activity not determined\", \"Whether other kinases act on these sites in specific tissues unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstration that iron chelation upregulates NDRG1 through both HIF-1α-dependent and -independent pathways, reversible by iron repletion, revealed iron as a master regulator of NDRG1 expression and connected NDRG1 to hypoxia and iron-metabolism signaling.\",\n      \"evidence\": \"Multiple iron chelators with inactive-binding-site controls, iron repletion, Northern/Western blot, and HIF-1α pathway dissection\",\n      \"pmids\": [\"15251988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factor binding to NDRG1 promoter under iron depletion not mapped\", \"Relative contribution of HIF-1α-dependent vs -independent pathways unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Localization of NDRG1 to centrosomes and its requirement for proper spindle formation and astral microtubule maintenance linked NDRG1 to mitotic fidelity and the p53-dependent spindle checkpoint, offering the first mechanistic connection between NDRG1 and genomic stability.\",\n      \"evidence\": \"Immunofluorescence centrosome localization, siRNA knockdown causing spindle defects, overexpression restoring spindle-checkpoint arrest in p53-null cells\",\n      \"pmids\": [\"15247272\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding partner at centrosomes not identified at this stage\", \"Whether centrosome role accounts for metastasis suppression unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two studies established NDRG1 as a regulator of receptor trafficking and a stabilizer of DNA-repair protein MGMT: NDRG1 controls LDLR endosomal sorting by opposing IDOL-mediated ubiquitylation and multivesicular body targeting, while NDRG1–MGMT interaction confers alkylating-agent resistance in glioblastoma, demonstrating that NDRG1 functions through specific protein–protein interactions rather than enzymatic activity.\",\n      \"evidence\": \"siRNA epistasis (NDRG1/IDOL co-depletion) with LDLR plasma-membrane and ubiquitylation readouts; Co-IP of NDRG1–MGMT with functional drug-resistance assays\",\n      \"pmids\": [\"23813961\", \"24367102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of NDRG1–MGMT and NDRG1–LDLR/ESCRT interactions not resolved\", \"Whether LDLR trafficking role extends to other cargo receptors unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of γ-tubulin as a direct NDRG1 binding partner resolved the centrosomal mechanism: NDRG1 maintains centrosome homeostasis downstream of p53, and its loss causes centrosome amplification, explaining NDRG1's role in genomic stability and mutual exclusivity with TP53 loss in cancers.\",\n      \"evidence\": \"Co-immunoprecipitation of NDRG1–γ-tubulin, RNAi and overexpression with centrosome counting, isogenic TP53 cell lines, cancer genomics\",\n      \"pmids\": [\"26324937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain on NDRG1 mediating γ-tubulin binding not mapped\", \"Whether phosphorylation state modulates centrosome engagement unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that NDRG1 is a T-cell clonal anergy factor induced by Egr2, degraded via phosphorylation and proteasome upon CD28/IL-2 signaling, expanded NDRG1's role beyond epithelial biology into adaptive immunity.\",\n      \"evidence\": \"Ndrg1 overexpression, conditional knockout mice, proteasome inhibitor treatment, T-cell anergy models\",\n      \"pmids\": [\"26507712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for CD28-triggered NDRG1 phosphorylation not identified\", \"Whether NDRG1's trafficking function underpins anergy mechanism unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"NDRG1 was shown to bind Nur77 and NF-κB to regulate endothelial inflammatory signaling; endothelial-specific NDRG1 knockout attenuated atherosclerosis, neointima formation, and arterial thrombosis, establishing NDRG1 as a pro-inflammatory mediator in endothelial cells — a role distinct from its tumor-suppressive function in epithelia.\",\n      \"evidence\": \"Co-IP of NDRG1–Nur77, endothelial-specific conditional knockout mice, carotid ligation and thrombosis models, luciferase reporters for NF-κB and AP-1\",\n      \"pmids\": [\"36562299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endothelial NDRG1 acts through the same trafficking mechanism as in epithelia not tested\", \"Structural basis of NDRG1–Nur77 interaction unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of mTORC2-mediated Ser336 phosphorylation as a signal that directs NDRG1 to mitochondria to drive DRP1-independent fission through cooperation with CDC42 provided the first direct organellar effector mechanism for phospho-NDRG1, linking nutrient sensing to mitochondrial dynamics.\",\n      \"evidence\": \"Live imaging, phospho-Ser336-specific antibodies, Rictor-KO and NDRG1-S336A epistasis, DRP1-KO cells, proteomics\",\n      \"pmids\": [\"37386153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of NDRG1–CDC42 cooperation at the mitochondrial surface not resolved\", \"Whether this fission mechanism operates in Schwann cells relevant to CMT4D unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"NDRG1 was found to prevent ATG9A-dependent autophagy-mediated degradation of MHC-I in pancreatic cancer, restoring antigen presentation and overcoming immune checkpoint blockade resistance, extending NDRG1's trafficking role to autophagy-mediated surface receptor regulation and anti-tumor immunity.\",\n      \"evidence\": \"Co-IP of NDRG1–ATG9A, orthotopic PDAC models, autophagy/proteasome inhibitors, flow cytometry for CD8⁺ T cells\",\n      \"pmids\": [\"38228036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NDRG1 broadly opposes selective autophagy of membrane receptors beyond MHC-I not tested\", \"Direct interaction domain mapping not performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The unifying structural basis for NDRG1's diverse protein–protein interactions (γ-tubulin, MGMT, Nur77, ATG9A, AR-HSP90, CDC42) remains unresolved: no high-resolution structure of full-length NDRG1 or its complexes exists, and how its alpha/beta hydrolase fold, CAP domain, and C-terminal repeat region coordinately engage different partners in different cellular contexts is the central open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No crystal or cryo-EM structure of full-length NDRG1 or any of its complexes\", \"How phosphorylation switches partner specificity is mechanistically undefined\", \"Whether NDRG1's role in Schwann cell trafficking and its mitochondrial fission function share a common membrane-remodeling mechanism is untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [19, 20, 21, 28, 33]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [24, 27, 30]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [13, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 7]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [13, 17, 21]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [31]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 24, 25, 27, 30, 31]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [13, 17, 21]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 2, 12, 26]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 33]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [19, 32]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"TUBG1\",\n      \"SGK1\",\n      \"GSK3B\",\n      \"MGMT\",\n      \"NR4A1\",\n      \"ATG9A\",\n      \"AR\",\n      \"CDC42\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}